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Sickle cell disease (SCD) is an inherited blood disorder, the natural history of which leads to degenerative 
avascular necrosis of the femoral head. The definitive long-term treatment for this debilitating condition is 
total hip arthroplasty. It is well established that the failure rate of the implants in these patients is very high 
and so leads to an increased revision burden. Literature has shown that all mammalian cells express the 
hypoxic inducible factor (HIF) which in the case of bone cells enhances osseointegration in a hypoxic 
environment. Within the in vivo physiologic environment in sickle cell patients, hypoxia is prevalent due to 
the sickling process, which leads to bony cellular hypoxia and then avascular necrosis. This research work 
was aimed at establishing if there was any structural reason for implant loosening due to the shape of the 
proximal femur in sickle cell disease patients. This study sought also to investigate the role of HIF in 
improving osseointegration by using an experimental model. It was important to ascertain if this model 
could give the needed physiologic assurance in the viability of osteoblasts cultured under hypoxic 
conditions.  
The clinical study used radiographic evaluation of proximal femurs of sickle cell disease patients, assessing 
them against established classifications to ascertain their shape and comparison drawn from osteoarthritic 
patients. In the experimental study, MG63 osteoblast cells were cultured under true hypoxic conditions (1% 
oxygen) in the presence of cobalt chloride and using the qualitative polymerase chain reaction (qPCR) 
process, the expression of HIF was evaluated. Using the same identical conditions as stated above, MG63 
cells was further cultured and their physiologic viability was assessed using the Alamar blue assay. 
The radiographic study showed clearly that sickle cell disease patients had well defined funnel shaped 
femurs but less so than the osteoarthritic cohort. This might allow for less press fit femoral component to be 
implanted and together with having less cortical thickness, there is a risk of occult and overt periprosthetic 
fractures which may contribute to femoral component loosening. The results from the experimental work 
confirmed that HIF could be up regulated in MG63 osteoblast cells in true hypoxic conditions made possible 
in the presence of cobalt chloride and that osteoblasts were viable despite the subnormal physiologic 
experimental conditions of hypoxia and cobalt chloride under which these cells were cultured. 
 From the clinical work undertaken, it was concluded that there might be structural reasons for the 
increased lack of osseointegration in sickle cell disease with femoral hip prosthesis. Furthermore, it was 
established that the experimental model used to investigate HIF expression and osteoblast cellular viability 
under hypoxic conditions could be deployed as an effective research tool for improving osseointegration in 
sickle disease patients with total hip replacement. It can be concluded from this work that cobalt chloride 
could be an agent for enhancing osseointegration, which is different from its current use as a bearing 
surface. This model could also be used in improving implant design to help address the increased total hip 
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AIMS AND STRUCTURE OF THESIS 
CHAPTER ONE - LITERATURE REVIEW 
This thesis was aimed at first reviewing sickle cell disease and its bony sequelae of 
avascular necrosis of the femoral head of which the total hip replacement is the long-term 
definitive treatment. We reviewed the various type of hip prosthesis fixation modes, 
mechanism of failure and the problems of high failure rate of hip implants in these patients. 
This contributes to the high revision burden they experience. The review also aimed at 
bringing to the fore the role of the hypoxic inducible factor (HIF), a transcription protein 
needed for osteogenesis in a hypoxic bony environment. This is the suboptimal macro 
cellular bone marrow environment where the femoral component for THR is implanted in 
sickle cell disease patients. The review further raised questions on how osseointegration 
could be improved in this environment. With this in mind, the need to develop experimental 
models to investigate this was obvious and hence the reason for the in vitro model designs 
and proposals in the subsequent chapters. 
CHAPTER TWO - RADIOLOGIC EVALUATION OF THE PROXIMAL FEMUR IN SICKLE 
CELL DISEASE PATIENTS 
Having identified the need to explore how to improve osseointegration in a hypoxic 
environment, we first aimed to establish if the shape of the proximal femur in SCD patients 
contributed to femoral component implant loosening. This was achieved through a 
comparative radiologic study of the proximal femur shape in sickle cell disease patients 
compared with similar osteoarthritic patients. A secondary objective was to also explore the 
variation in the shape of the proximal femur in these patients and characterize it. 
CHAPTER THREE – THE EXPERIMENTAL STUDY TO INVESTIGATE A POTENTIAL 
MODEL FOR IMPROVED OSSEOINTEGRATION IN SICKLE CELL BONE DISEASE 
PATIENTS WITH AVASCULAR NECROSIS 
The need to investigate and improve osseointegration forms part of the basis for successful 
hip arthroplasty treatment in patients. We therefore sought to explore this physiologic 
phenomenon by setting up in vitro experimental models, which would be able to mimic the 
hypoxic in vivo pathologic environment seen in SCD patients, and see if over expression of 




CHAPTER FOUR - INVESTIGATING CELLULAR VIABILITY OF MG63 CELLS WITH 
COBALT CHLORIDE IN AN HYPOXIC ENVIRONMENT- A PROPOSED IN VITRO MODEL 
 
We also wanted to explore the viability of osteoblasts in the above - enhanced hypoxic 
environment. This was investigated through another experimental in vitro model with MG63 
cells cultured with cobalt chloride. Through this model, the objective of checking the 
functional potential of osteoblasts was going to be assessed in order to lend some credence 
to the previous experimental study and somehow authentic its future effectiveness. We hope 
that this study could form the basis for improved femoral implant design, which can be used 
in improving osseointegration in these patients. 
 
CHAPTER FIVE- GENERAL DISCUSSIONS 
We hope with the results of this work, that improvements could be made to the experimental 
model proposed. This can be seen as the first building blocks to further explore the design of 
in vivo models, which could later form the basis for knowledge transfer into clinical practise 
for the improvement of hip implant survival in sickle cell disease patients. 
 
CHAPTER SIX - FUTURE WORK AND PROPECTS 
With the scientific literature being devoid of little evidence into experimental models 
investigating osseointegration particularly in sickle cell disease patients, this research study 
may be able to led the way in developing improved osseointegration focused in vitro models. 
These models could aim at improving osseointegration in these sickle cell patients with 
regards their hip implants and this would reduce significantly their surgical hip revision 
burden. Furthermore, it is possible that with this work, some ideas targeted at improving hip 
femoral implant design with regards coating the femoral implant surface with osteogenic 
proteins such as HIF could be seen in the near future and used in sickle cell disease patients 











Avascular necrosis (AVN) of the femoral head remains a common complication in sickle cell 
disease (SCD) patients and this is frequently bilateral. This is caused by infarctions which 
results from occlusion of the vasculature by red blood cells (erythrocytes) which have 
changed shape to flow less smoothly in the blood vessels. The red blood cells take the 
shape similar to a crescent or sickle hence the name of the disease. This makes them less 
passible through blood vessels compared to normal rounded erythrocytes. In addition, this 
abnormal shape makes them adhere to other erythrocytes and the vascular endothelial walls 
causing occlusion, bone marrow ischemia and eventual progression to AVN (Ilyas & Moreau, 
2002; Sanders, 2018).  
Total hip replacement (THR) surgery is often necessary to treat the degeneration which 
results from AVN (Hanker & Amstutz, 1988). However, it has been noted that the outcome 
and survivorship of this procedure in SCD patients is relatively poor in comparison with THR 
from other aetiologies and the failure of osseointegration is attributed as a major underlying 
reason (Acurio & Friedman, 1992; Amstutz & Le Duff, 2016; Bishop, Roberson, Eckman, & 
Fleming, 1988). There is still robust debate out there in the orthopaedic surgical community 
on the choice between using cemented or uncemented implants or even still hybrid 
(combination of cemented and uncemented components) in the definitive treatment of AVN 
in SCD. However there is emerging current literature that has shown some promising results 
with the use of uncemented prosthesis (Gulati et al., 2015) which this review would further 
elaborate on. 
This chapter seeks to outline the sickle cell bone disease epidemiology, pathophysiology, 
the treatment and recognized complication of implant loosening which these patients have. It 
also seeks to shine the light on the physiologic phenomenon of osseointegration and how 
the study of this has influenced orthopaedic implant design. It identifies some of the various 
in-vitro studies used to investigate this phenomenon and how any of these studies have 
affected hip arthroplasty surgery in sickle cell disease patients. 
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Many studies were carried out to evaluate the various cellular and molecular processes 
involved in osteogenesis. Angiogenesis and bone formation work closely together in this 
(Wang et al., 2007). The hypoxia inducible factor (HIF) which is stimulated in tissue hypoxia 
triggers a cascade of molecular processes that helps manage this physiologic deficiency 
(Keith & Simon, 2007; Lampert, Kutscher, Stark, & Finkenzeller, 2016). However, there 
remains a paucity of knowledge concerning how sickle cell bone pathology in particular 
avascular necrosis can be altered when it comes to osseointegration at the molecular level. 
The Hypoxia Inducible Factor has been identified as a key factor in mediating how cells 
adapt to molecular oxygen levels. 
This review further elucidates the physiology of the hypoxic inducible factor with its various 
pathways and establishes what role this factor could play in altering the pathophysiology of 
avascular necrosis caused by sickle cell disease. It seeks to establish certain research 
methodology frameworks in exploring how osseointegration can be improved in these 
patients with prosthetic implants especially total hip replacements. 
One major purpose to this literature review is to highlight questions with regards the paucity 
of experimental models in the current literature that will help form the basis for research to 
improve osseointegration in SCD patients. With considerable prior work having been 
undertaken to understand the mechanism of microcellular bony hypoxia, the current study 
set out to bring to the fore the need to investigate further potential in vitro experimental 
models which will mimic the in vivo pathologic setting in sickle cell avascular necrosis. This 
may help lead to creating some foundation building blocks that could help form the basis for 
directed research at improving osseointegration in sickle cell disease patients. 
 
1.1 SICKLE CELL BONE DISEASE 
 
Sickle-cell disease is an inherited blood condition common among, but not confined to, 
peoples of Equatorial African ancestry. The gene for sickle haemoglobin (HbS) results in the 
substitution of valine for glutamic acid normally present at the sixth position from the amino 
terminus of the chain of haemoglobin. It is acquired by inheriting abnormal genes from both 
parents, the combination giving rise to different forms of sickle cell disease. Most common at 
birth is homozygous sickle-cell (SS) disease, also called sickle-cell anaemia, in which the 
HbS gene is inherited from both parents (Serjeant, 1997). 
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Sickle-cell disease (SCD) encompasses various combinations of abnormal haemoglobin 
genes that include at least one copy of the gene for haemoglobin S paired with another 






People living in Africa have the highest burden of sickle-cell disease, predominantly due to 
four types of abnormal haemoglobin combinations: haemoglobin SS (sickle-cell anaemia), 
haemoglobin SC, haemoglobin Sβ+ thalassemia, and haemoglobin Sβ0 thalassemia. The 
sickle cell trait is widespread throughout Africa with low frequencies (<1%–2%) in the north 
and south of the continent and high but variable frequencies throughout much of equatorial 
Africa (Nagel et al., 1985; Pagnier et al., 1984). Some estimated 300,000- 400,000 babies 
are born with sickle cell anaemia (SCA) worldwide every year. Approximately 75% of these 
births occur in sub-Saharan Africa (Kato et al., 2018; Macharia et al., 2018; D. C. Rees, 
2014)  (See Figure 1.1).  Population estimates in the United States suggests that 
approximately 100,000 people have the disease. It is estimated that three countries in the 
world account for the majority of babies with sickle cell disease. These countries are Nigeria, 
Democratic Republic of Congo and India. Unfortunately the mortality of children under 5 
years with the condition can be as high as 90% (Grosse et al., 2011). Demographic 
projections estimate that by 2050, the number of newborn babies with SCA worldwide will 
increase by a third and in the above-mentioned countries there would an increase of 30% 
(Piel, Hay, Gupta, Weatherall, & Williams, 2013; Ware, de Montalembert, Tshilolo, & 
Abboud, 2017). 
 
Importantly for Europe, there are scarce non-current data to the best of our knowledge for 
prevalence of sickle cell disease in the region. However in 2010, it was reported that about  
over 3,000 children are born with SCD every year in the region (Piel et al., 2010). This figure 
could be unreliable bearing in mind the significant migration into Europe in recent years and 
substantial number of children are being born in areas where SCD is considered rare (for 
example northern and western Europe) (Thein, Igbineweka, & Thein, 2017). The total 
number of patients with SCD among migrants in Germany was estimated at 2,106 in 2007 
and 3,216 in 2015, which is an increase of 60% (Kunz et al., 2017). It is also worth noting 
that in a sickle cell multicenter study carried out in both United Kingdom and France, 









Figure 1.1 Map of the estimated numbers of births with sickle cell anaemia              















1.1.2 EPIDEMIOLOGIC PROFILE FOR AVASCULAR NECROSIS IN SICKLE CELL   
DISEASE 
The femoral head is the most commonly affected site for AVN followed by the humeral head. 
Studies in the literature reported the incidence of osteonecrosis of the femoral head (ONFH) 
in SCD could vary from 3%-50% (Issa et al., 2013). The co-operative study of SCD reported 
that the estimated age for the diagnosis for AVN was 28 years and age-specific prevalence 
rate was highest in patients who were over 45 years of age (34.9%) (Thein et al., 2017). In 
contrast, the prevalence among patients under 25 years was approximately 6%. 
Furthermore, it is important to note that AVN is a complication associated with age, with 
incidence higher in the older patient. Some studies have shown that the prevalence of 
osteonecrosis of the femoral head is approximately 3% in patients under 15 years and could 
be as high as 50% in over 35 (Almeida-Matos, Carrasco, Lisle, & Castelar, 2016). Ortiguera 
et al in their series noted that the 50% revision rate in patients who had THR was due to 
osteonecrosis. However, Johannsson et al in their study postulated that osteonecrosis in 
itself is not a predictor of high failure rate in THR but highlighted that the high revision rate in 






The most important pathophysiological event in sickle cell anaemia that explains most of its 
clinical manifestations is vascular occlusion. This involves both the micro- and 
macrovasculature. Osteonecrosis is caused by the interruption of blood flow, limiting the 
delivery of oxygen and nutrients, and leading to necrosis of bony tissue. (Ballas, 2002; 
Chughtai et al., 2017). Haemoglobin polymerization leading to erythrocyte rigidity and 
vasocculsion, is central to the pathophysiology of this disease (David C. Rees, Williams, & 
Gladwin, 2010). Kaul et al noted in their review of the pathophysiology of vascular 
obstruction in sickle cell syndromes that red cell destruction leads to enhanced cell vascular 
adhesion which invariably led to more vasocculsion (Figure 1.2A and 1.2B). 
Bone involvement is the commonest clinical manifestation of sickle cell disease both in the 
acute setting such as painful vasocclusive crisis and as a source of chronic, progressive 
disability such as avascular necrosis (Almeida & Roberts, 2005; Kaul, Fabry, & Nagel, 1996). 
AVN of the femoral head is one of the significant complications affecting the musculoskeletal 
system in patients with sickle cell haemoglobinopathy. The reported incidence of femoral 
head necrosis varies from less than 10% to more than 30% (Ellis & Chaudhuri, 2007; 
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Mavrogenis, Dimitriou, Parvizi, & Babis, 2009). In many patients, both hips and other bones 
are affected. The pathophysiology of osteonecrosis in sickle cell disease seems to differ 
from osteonecrosis because of other aetiologies. When magnetic resonance imaging (MRI) 
is used to quantify lesions in AVN of the femoral head, the lesions seen in sickle cell disease 
are larger than those seen in osteonecrosis due to other aetiologies (Malizos et al., 2007).   
In osteonecrosis from other causes, the localization and size of the lesions is directly related 
to the mechanical stresses on the femoral head. The larger size and wider distribution of the 
lesion in sickle cell disease is due to variety of independent factors which result in vascular 




Figure 1.2 (A) shows normal red blood cells flowing freely in a blood vessel. The inset image 
shows a cross-section of a normal red blood cell with normal haemoglobin. 
 Figure 1.2 (B) shows abnormal, sickled red blood cells blocking blood flow in a blood vessel. 
The inset image shows a cross-section of a sickle cell with abnormal (sickle) haemoglobin 
forming abnormal strands. 
Reference: Source-	http://www.nhlbi.nih.gov/health/health-topics/topics/sca/ The National 
Heart, Lung, and Blood Institute (NHLBI)-Image in public domain 
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1.3 TOTAL HIP REPLACEMENT FOR SICKLE CELL DISEASE 
As noted earlier, AVN of the femoral head is a common consequence of vasocclusive 
attacks. The small blood vessels of the femoral head with its specific blood supply and lack 
of collateral circulation are particularly liable to occlusion by sickled cells. Local thrombosis 
gives a further reduction of the oxygen tension, resulting in increased sickling. This vicious 
cycle of continued hypoxia and sickling eventually produces infarction, necrosis, femoral 
head collapse and joint degeneration and destruction (Figure 1A).  Hip symptoms are 
commonly seen in the second and third decades in these SCD patients. Hip replacement 
arthroplasty is becoming a more frequent operation in the management of those patients 
who have passed the stage of more conservative surgery. Decision for surgery is based on 
severity of pain and functional disability. Advances in medical treatment have led to 
improved life expectancy in sickle cell patients, which in turn lead to an increasing number of 
patients requiring Total Hip Replacement (THR) (Acurio & Friedman, 1992; Al-Mousawi et 
al., 2002; Meier, 2018). 
 
1.3.1 BASIS FOR IMPLANT FIXATION AND FAILURE 
As a preamble, it would be ideal to review briefly the biomechanical basis for which 
cemented and uncemented implants achieve bonding in hip arthroplasty. Long-term fixation 
of component parts of prosthetic joint replacement is accomplished with cement 
polymethylmethacrylate (PMMA) or uncemented fixation. The cemented fixation is achieved 
with static mechanical micro-interlock of the PMMA with the endosteal bone. The cement 
may undergo fatigue and then micro fractures could occur with cyclic loading. As cement 
cannot remodel, the implant will ultimately loosen. Cemented cups have been noted to have 
a higher rate of failure especially in younger patients (of which SCD patients belong to this 
demographic group). The acetabular cup is positioned at an angle relative to the longitudinal 
axis of the leg and this creates shear tension forces at the cement-bone interface. PMMA is 
weaker in tension and stronger in compression and hence the lower femoral failure rate of 
cemented femoral stems as compared to the cups (Miller. M.D, 2016). However, young 
active patients have increased failure over time. Some autopsy studies have shown that 
long-term failure of the fixation of cemented femoral components was primarily mechanical, 
starting with debonding at the interface between the cement and the prosthesis, and 
continuing as slowly developing fractures in the cement mantle (Jasty et al., 1991) but 
modern implant design and cementation techniques have helped to improve survival rates in 
these cases. 
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The uncemented implants achieve bonding via biologic fixation. This is done using 
prosthesis fabricated with metal pores. Bone grows into the porous structure stabilizing the 
implant unto bone. Successful bone ingrowth is based on optimal pore size (50-150μm), 
optimal metal porosity, minimal implant micro motion, and cortical contact with bone. Some 
of these factors are ensured with the use of modern uncemented implants hence their use in 
younger patients including SCD patients with AVN. The initial rigid implant fixation to host is 
required for long term osseointegration (Ballas, 2002; Miller. M.D, 2016; Ramachandran 
Manoj, 2006). Despite the limitation and complications of uncemented implants which 
include proximal-distal mismatch, non-ideal load transfer, loss of bone, difficulties with 
minimally invasive surgery, periprosthetic fractures (Patel, Smith, Woodward, & Stulberg, 
2012), their preferred use in younger patients has formed their functional use in SCD 
patients. Therefore, for this review we have focused on the investigation of osseointegration 




1.3.2 CEMENTED VERSUS UNCEMENTED IMPLANTS 
Early published series of THR among SCD patients reported high complications and failure 
rate ranging between 18% and 100%. Improvement in intra and postoperative care and 
especially of the implant design has resulted in better outcome in reports within the last 
decade (Al Omran, 2013). Clarke et al noted in their series of cemented THR cases, a high 
morbidity in sickle cell disease patients due to implant loosening (Clarke, Jinnah, Brooker, & 
Michaelson, 1989). Other complications (intra-operative and immediate post-operative) in 
these patients include, deep infection, acetabular protrusion and femoral shaft injury (Al-
Mousawi et al., 2002; Bishop et al., 1988).  Acurio et al  noted a 40% revision rate at 7.5 
years due to either radiologic and/or symptomatic implant loosening in cemented implants 
(Acurio & Friedman, 1992) (See Table 1.3Aa). Having noted earlier that sickle cell patients 
with THR are young, the revision rate associated with total hip arthroplasty with cement in 
young patients has been reported to range from 5% to 49% over follow-up periods of sixteen 
to twenty-three years. The reported rates of revision of acetabular components in young 
patients have ranged from 1% to 40% at fifteen years postoperatively (Callaghan, Forest, 
Olejniczak, Goetz, & Johnston, 1998; Dorr, Kane, & Conaty, 1994; Smith, Estok, & Harris, 
2000). These rates are quite high; however, these studies were carried out before the advent 
of modern cementing techniques that included the use of a distal cement plug to occlude the 
canal, washing and drying the canal with retrograde filling using a cement gun. 
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Pressurization then achieved using a proximal seal and the injection of further cement once 
the canal had been filled (Maggs et al., 2016). It is documented in the literature that the use 
of cement is likely to cause thermal necrosis of already infarcted bone contributing to higher 
incidence of infection and loosening. However, Hernigou et al (Hernigou, Bachir, & 
Galacteros, 1993; Hernigou et al., 2008) reported long-term results for a large series of 
patients with SCD who underwent cemented THR and had promising results compared to 
others (Table 1.3a). They postulated that low rate of implant loosening seen in their results 
was associated with the use of the “French Paradox” technique. This involves using a largest 
possible rectangular canal filling titanium alloy stem without trying to obtain a continuous 
cement mantle. They explained that the rectangular cross section and direct load transfer to 
the bone by close cortical contact provided intrinsic stability within the femur which in turn 
might have protected the cement mantle (Langlais, Kerboull, Sedel, & Ling, 2003). It can 
therefore be suggested that cemented THR could be used with caution in these patients 
because loosening is a major concern for both femoral and acetabular components (Ilyas, 
Alrumaih, & Rabbani, 2018).  
 
Table 1.3a Literature Review for studies with cemented Total Hip Arthroplasty for Sickle Cell  
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46 12 2.2 36.9 21.7 60.8 
 
 
Various reasons have been postulated for the high rate of implant loosening with 
uncemented prostheses. First, earlier series published showing poor results could be due to 
lack of now improved implant design in uncemented implants (See Table 1.3b). Also, due to 
the chronic anaemia seen in SCD patients, the medullary cavity widens and there is thinning 
of the cortices. This usually occurs in the metaphyseal region of long bones such as the 
proximal femur producing weakness, increased chance of fracture and a less than optimal 
environment for a femoral prosthesis. Bone marrow hyperplasia and repeated infarctions 
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produces a less favorable biologic environment for the prosthesis leading to high failure rate 
of acetabular and femoral components. It has also been suggested that lack of bone in-
growth (osseointegration) in these patients could contribute to the high loosening rate in 
them but this is yet to be verified by autopsy studies (Acurio & Friedman, 1992; Al Omran, 
2013). Histologic along with a concurrent magnetic resonance imaging study did conclude 
that acetabular necrosis might be an accompaniment to aseptic necrosis of the femoral 
head. Further work is required to assess its importance in premature loosening of the 
acetabular element of total hip arthroplasty (Fink, Assheuer, Enderle, Schneider, & Ruther, 
1997). Furthermore, it is worth noting that large cohort studies have shown that the mean 
age of patients having THR for AVN in SCD is 36 years and so high level of activity in these 
patients does contribute to increased implant loosening rate. Seeing that these patients are 
generally young, biologic fixation with modern uncemented implants could be a more 
attractive option. More recent published large cohort studies with long term follow up in SCD 
with uncemented THR implants have shown very encouraging results so far (Ilyas et al., 
2018; Jack, Howard, Aziz, Kesse-Adu, & Bankes, 2016; Katchy, Anyaehie, Nwadinigwe, & 
Eyichukwu, 2018).  
 
 
Table 1.3b Literature review for studies with uncemented Total Hip Arthroplasty for Sickle 
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(Ilyas et al., 
2018) 







1.3.3 - HYBRID IMPLANTS FOR SICKLE CELL DISEASE PATIENTS 
 
Farook et al noted in their review that hybrid implants (combination of cemented and 
uncemented THR components) could be an option in these patients. As is the case with both 
cemented and uncemented implants, it has been noted that there were much higher revision 
rates in earlier studies (See Table 1.3c). In their own study of 34 patients who underwent 
THR with hybrid implants, there was a revision rate of 17.6 % as compared to an earlier 
similar study with 35 patients but with a revision rate 40-59% (Acurio & Friedman, 1992; 
Farook et al., 2018). This difference could be due to the better design of cemented implants 
and the use of improved cementing techniques. Kim et al concluded in their series of young 
patients with OFN that contemporary uncemented cups and cemented or uncemented stems 
provide durable long-term fixation and substantial pain relief well into the second decade 
after the operation. Although the long-term fixation of the acetabular metallic shell and 
cemented or uncemented femoral stem was outstanding, wear and periacetabular osteolysis 
constitute the major challenge associated with these contemporary total hip arthroplasties 
with or without cement in young patients with osteonecrosis of the femoral head (Y. H. Kim, 
Kim, Park, & Joo, 2011). 
 
Table 1.3c- Literature Review- for studies with a mix of uncemented, cemented and hybrid 


















































Osseointegration refers to a direct structural and functional connection between ordered, 
living bone and the surface of a load-carrying implant. It can also be referred to as a direct 
bone-to-metal interface without interposition of non-bony tissue. Branemark who first 
described this phenomenon showed that titanium implants could become permanently 
incorporated within bone that is, the living bone could become so fused with the titanium 
oxide layer of the implant that the two could not be separated without fracture (Shubayev, 
Branemark, Steinauer, & Myers, 2004). An implant is considered as osseointegrated when 
there is no progressive relative movement between the implant and the bone with which it 
has direct contact. Essentially, the process of osseointegration reflects an anchorage 
mechanism whereby non-vital components can be reliably incorporated into living bone and 
which persist under all normal conditions of loading. The biology of osseointegration involves 
the events that are similar to those occurring during bone healing. Various cell types, growth 
factors and cytokines are involved and interact throughout the stages of osseointegration, 
including inflammation, vascularization, bone formation and ultimately bone remodeling 
(Dimitriou & Babis, 2007).  
 
Factors may enhance or inhibit osseointegration. Factors, which promote osseointegration, 
include implant-related factors such as implant design and chemical composition, 
topography of the implant surface, material, shape, length, diameter, implant surface 
treatment and coatings, the status of the host bone bed and its intrinsic healing potential. 
Others include the mechanical stability and loading conditions applied on the implant, the 
use of adjuvant treatments such as bone grafting, osteogenic biological coatings and 
biophysical stimulation and pharmacological agents such as simvastatin and 
bisphosphonates.  It is important to achieve the best possible implant osseointegration into 
the adjacent bone and therefore to ensure long-term implant stability. For this purpose, 
various pharmacological, biological or biophysical modalities have been developed, such as 
bone grafting materials, pharmacological agents, growth factors and bone morphogenetic 
proteins. Biophysical stimulation of osseointegration includes two non-invasive and safe 
methods that have were initially developed to enhance fracture healing: pulsed 
electromagnetic fields (PEMFs) and low intensity impulse ultrasounds (LIPUS), for which 
most studies confirm their beneficial effects. Factors, which inhibit osseointegration, include   
excessive implant mobility and micro motion, inappropriate porosity of the porous coating of 
the implant, radiation therapy and pharmacological agents such as cyclosporine A (Dimitriou 
& Babis, 2007; Mavrogenis et al., 2009). 
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There have been studies looking at osseointegration in relation to biomaterials, and implant 
surgery.  Despite advances in total hip arthroplasty, failure of acetabular cups in total hip 
arthroplasty remains a concern and more so when those affected are sickle cell disease 
patients. Kalia et al noted in their study that Osseointegration improved with acetabular cups 
sprayed with bone marrow stromal cells (Kalia et al., 2009). Other studies have concluded 
that other biomaterials such as zirconium had similar biocompatibility and osseointegration 
to titanium implants (Moller et al., 2012). Alternatively, surface topography modifications and 
physiochemical treatments of surfaces to achieve an enhanced bone implant interface 
formation using biochemical methods offer an alternative path. These functionalization 
approaches require a deeper understanding of biology and biochemistry of the host tissue at 
the interface in terms of mechanisms by which cells adhere to surfaces, the role of 
biomolecules, functional peptide sequences and extracellular matrix proteins in influencing 
or regulating differentiation and remodeling of bone and tissue (Bauer, S, Mark, & Park, 
2013).   
In the field of dental surgery, some considerable research work has been done to further 
investigate osseointegration. Du et al established in their work on the ultrastructural 
relationship between dental implants and osteocytes following osseointegration that there 
was direct anchorage of osteocytes and dendritic processes to titanium implant surface in 
vivo (Du, Ivanovski, Hamlet, Feng, & Xiao, 2016).  It has also been postulated in another 
study that the in vivo performance of the micro arc oxidation coated strontium (MAO-Sr) 
coated dental implants with regards rapid osseointegration was comparable to that of 
commercially available titanium implants and so suggesting a novel implant which enhance 
osseointegration through angiogenesis and osteogenesis (W. Zhang et al., 2016). Despite 
the above studies, there is no work in the established literature directed at addressing 
implant failure due to lack of osseointegration in sickle cell disease patients. In addition, to 
the best of our knowledge there has been no experimental models described in the 
literature, which investigates the pathogenesis and in vivo sequelae of SCD. This review and 
the subsequent experimental studies could help lay building blocks for potential future 











1.5 HIF AND ITS ROLE IN OSSEOINTEGRATION 
Oxygen, an indispensable metabolic substrate in various enzymatic reactions in vivo 
including mitochondrial respiration, is a key regulatory signal in tissue development and 
homeostasis. For example, during embryonic development, cellular differentiation as well as 
organ growth and final shape are thought to be modulated by oxygen gradients, which, at 
least in part, rely on the hypoxia-inducible factor (HIF) signaling pathway to mediate their 
effect (Maes, Carmeliet, & Schipani, 2012). At a molecular level, a HIF complex contains an 
alpha and beta subunit, both of which can be selected from several alternatives. They are 
members of a large family of transcription factors, which contain a basic helix–loop– helix 
region, and a PAS domain (named for Per, Arnt/HIF- 1β and Sim). HIF β subunits are 
constitutive and are involved in xenobiotic responses. The α subunit is regulatory and is 
unique to the hypoxic response (Maxwell, 2005). The HIF family comprises three subunits: 
HIF-1alpha, HIF-2alpha and HIF-3alpha. HIF-2alpha and HIF-3 alpha have limited homology 
with HIF-1alpha, but all three subunits share the conserved Von Hippel–Lindau (vhl) -
binding domain and are consequently regulated by hypoxia in the same way as HIF-1 alpha 
(Wiesener et al., 1998). 
There is established evidence that HIF1α promotes angiogenesis and osteogenesis by 
elevating VEGF levels in osteoblasts. Wang and Wan et al showed in their study that mice 
overexpressing HIF-1α in osteoblasts through selective deletion of the Von Hippel–Lindau 
gene (vhl) expressed high levels of VEGF and developed extremely dense, heavily 
vascularized long bones and they showed a model for the HIF-1α pathway in bone 
formation. In this model, osteoblasts residing on the nascent bone surface sense reduced 
oxygen or nutrient levels and upregulate HIF-1α subunits. Elevated HIF1α transactivates 
target genes such as VEGF, which then stimulate new blood vessel formation and invasion 
into bone. This process is exponential, with ever-increasing numbers of new blood vessels 
introducing more osteoblast progenitors, which then mature and function to form more 
individual bone formation units (Wang et al., 2007). Wan and Shao et al described in their 
own in vitro study that the hypoxic inducible factor-1 alpha (HIF-1) pathway has been 
identified as a key component in this molecular process. They demonstrated that 
overexpression of HIF-1α in mature osteoblasts through disruption of the Von Hippel-Lindau 
protein profoundly increases angiogenesis and osteogenesis (Wan et al., 2010). However, 
current literature does not point to evidence of a model used in chronic hypoxia to study the 
role of HIF in osteogenesis and this is a potential research avenue which could be explored. 
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The decisive role of the implant surface properties on molecular interactions, cellular function 
and bone regeneration has been demonstrated extensively in in vitro research. However, a 
thorough understanding of the genetic scale of the onset phase of bone regeneration at the 
implant interface is required prior to the development of strategies to optimize implant 
osseointegration (Vandamme et al., 2011b). 
It was concluded in a study that angiogenic events are crucial for subsequent implant 
osseointegration. Their finding that the gene expression of angiogenic markers is differently 
regulated in normal versus compromised bone at 2 days after implantation strengthens this 
requirement. This event coincides with a negatively affected osteogenic cell response and 
results in a suspended implant osseointegration in compromised bone. (Vandamme et al., 
2011a). 
 
This now calls into question the role of HIF with regards osseointegration. Vandamme et al 
also noted in their study that HIF1 alpha expression increased in the initial phase of 
osseointegration and hence VEGF up-regulation. There are studies which have evaluated 
the role of implants surfaces and their role in osseointegration. Park J et al showed clearly in 
their study that the Strontium (Sr) containing oxide layer produced by hydrothermal 
treatment was effective in improving the osseointegration of Titanium (Ti) – 6Aluminium–4V 
alloy implants by enhancing differentiation of osteoblastic cells (Park et al., 2010). In 
addition, studies have provided evidence that osteoblast attachment, as well as alkaline 
phosphatase (ALP) activity and calcium deposition was enhanced by the immobilized VEGF 
on the polysaccharide-grafted Titanium. Thus, Titanium substrates modified with 
polysaccharides conjugated with VEGF can promote osteoblast functions and concurrently 
reduce bacterial adhesion (Hu et al., 2010). 
 
It has also been determined that osseointegration between tissue engineered bone and 
dental implants was enhanced by HIF-1α (Zou et al., 2012). However, there is no literature 
evidence in the role of HIF’s molecular physiology being used in promoting the prospect of 
osseointegration in pathologic bony conditions involving chronic hypoxia. There could 










1.6 THE ROLE OF HIF IN CHRONIC HYPOXIA AND ITS EFFECTS 
OSSEOINTEGRATION 
 
Human mesenchymal cells (hMSCs) are multipotent cells, as they are capable of 
differentiating along the osteogenic, adipogenic and chondrogenic lineages as previously 
demonstrated by numerous studies. Potier and Ferrieria et al described in their own study 
that temporary exposure of mesenchymal stem cells to hypoxia leads to limited stimulation 
of angiogenic factor secretion and to persistent down-regulation of several osteoblastic 
markers, which suggests that exposure of MSC transplanted in vivo to hypoxia may affect 
their bone forming potential. They also established in their study that there was a 2-fold up-
regulation of vascular endothelial growth factor (VEGF) expression by hMSCs occurs under 
hypoxic conditions at both mRNA and protein levels. These findings are in agreement with 
previous reports that hypoxia increases VEGF expression (Potier et al., 2007). However, a 
limitation in this study was the methodology in creating the hypoxic environment for cell 
growth - without the use of modern oxygen incubators accurate readings for the partial 
pressure of oxygen (O2) at cellular level would be difficult to achieve. Diverse responses to 
hypoxia have been reported for cultured osteoblasts, including increased synthesis of 
(VEGF), insulin-like growth factor II (IGF-II), and transforming growth factor β1 (TGF β1) 
(Akeno, Czyzyk-Krzeska, Gross, & Clemens, 2001; Warren et al., 2001). The long-term 
effects of hypoxia on the function of osteoblasts, the bone forming cells, have received little 
direct attention (Utting et al., 2006). It was highlighted in the study that exposure of 
osteoblasts to hypoxia (2% O2) for the first 6 days of culture followed by 20% O2 for the final 
12 days resulted in a three-fold decrease in bone nodule formation and the reverse led to a 
two-fold decrease in bone nodule formation. They saw that the amount of bone nodule 
formation in cultures subjected to early hypoxia added to that measured in cultures 
subjected to late hypoxia, approached that of cultures held at 20% O2 continuously, 
indicating that osteoblasts are able to recover from hypoxic insult. This type of insult mimics 
that seen in sickle cell disease patients who may eventually develop necrosis (Utting et al., 
2006). 
 
It is worth noting that HIF activation causes angiogenesis, which is a prerequisite for 
osteogenesis and then osseointegration (Wang et al., 2007). New bone forms only in close 
connection to blood vessels. The mature bone cell does not survive more than 200 µm away 
from a blood vessel. First, the blood vessel develops and then the bone follows, a process 
called angiogenetic osteogenesis (Terheyden, Lang, Bierbaum, & Stadlinger, 2012). Bone 
formation by osteoblasts is critically dependent on oxygen and provide further evidence for 
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the vital role of the vasculature in maintaining bone health (Utting et al., 2006). With the 
understanding that osteoblasts can be genetically modified in order to cause the 
overexpression of HIF 1 alpha (Wan et al., 2010) and then leading to increased 
osteogenesis, we propose that this concept be used in an experimental in vitro research 
model. This is to study the degree of osseointegration with these modified osteoblasts when 
exposed to chronic and repeated hypoxic insults as seen in vivo with sickle cell disease 
(SCD) patients with prosthetic implants. With hypoxia being both a cause and sequelae of 
SCD (Hargrave, Wade, Evans, Hewes, & Kirkham, 2003), there would be important clinical 
implications  from the above proposal in improving osseointegration in these patients. 
Mimicking the in vivo pathologic microcellular environment seen in these patients, the above 
model proposed could be the first stepping-stone into developing prosthetic hip implants that 
would help solve the problem of implant loosening and lack of osseointegration 
characterized in SCD patients with total hip arthroplasty. 
 
 
1.7 EXPERIMENTAL MODELS FOR HYPOXIC INDUCIBLE FACTOR (HIF) EXPRESSION 
 
It would be important to explore the various models used in the literature in the over 
expression of HIF. HIF-1α plays a key role in hypoxia response, including glucose 
metabolism, vascular remodeling, and erythropoiesis. As this protein is expressed by 
mammalian cells in response to hypoxia, this leads to various angiogenic and osteogenic 
processes in which different cells lines have been used to express it in vitro (Sun & Peng, 
2015).  
 
1.7.1 CELL TYPE 
 
Mesenchymal stem cells (MSC), osteoblast-like osteosarcoma cells (MG63 cells), 
adipocytes and other cells have been used. However, for the purpose of this review as it is 
related to avascular necrosis in sickle cell bone disease, we have focused on MSCs and 
osteoblasts. MSCs have shown increased proliferation under hypoxia with over expression 
of HIF while other studies have revealed the opposite (Holzwarth et al., 2010; Peng, Shu, 
Lang, & Yu, 2016). The difference in these results may be due to donor specific differences 
or origin of tissues from which the MSCs have been isolated. It has been well documented 
that age-related cellular impairment associated with cell proliferation, senescence and stem 
cell plasticity has been seen based on the various tissues from which the MSCs have been 
derived from (Sun & Peng, 2015). MG63 cells on the other hand is known to form a 
monolayer more rapidly and does this easily (Czekanska, 2011; Heremans, Billiau, 
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Cassiman, Mulier, & de Somer, 1978). In addition to their long culture life, they do have a 
surface integrin subunit profile, which has been noted as being effective and useful for cell 
attachment on various materials, therefore making it a well-used cell type for not only culture 
studies but also studies involving HIF expression (Czekanska, 2011). It is also worth noting 
that MG63 cells are much cheaper to purchase than MSCs (Sigma-Aldrich, 2019). 
 
 
1.7.2 MODEL FOR HIF EXPRESSION (IN VIVO OR IN VITRO) 
 
Most of the models used for the expression of HIF were mostly in vitro but recently more in 
vivo models have been used to investigate HIF in various specific conditions. It is obvious 
that in vitro models may be much easier to set up and can be modified to investigate various 
conditions (Liu et al., 2019). In vivo models go a long way in validating the expression of HIF, 
as this is much more akin to what occurs in the human body. In vivo models also have the 
advantage of mimicking authentically the pathologic human conditions hence results are 
more representative.  While in vivo models capture the complexity of the macro-process in a 
living system, investigation of the individual steps is challenging and extracting quantitative 
mechanistic data is usually very difficult. In contrast, in vitro models have reduced 
physiological relevance, capturing only limited aspects of the microenvironment, but allow 
control of most experimental variables and permit quantitative analysis. With the drive 
towards precision medicine being on the rise, it is not uncommon to see in vitro research 
models being adapted for patient specific pathologies and therapies as can be seen and 
could relate to one of the aims of this index research work (Katt, Placone, Wong, Xu, & 
Searson, 2016). 
 
1.7.3 REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION (RT qPCR) 
VERSUS ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) IN HIF EXPRESSION 
 
Broadly speaking, most of the models used in the analysis of the expression for HIF have 
used reverse transcriptase quantitative polymerase chain reaction rather than ELISA (Lai et 
al., 2017; Sun & Peng, 2015) . There are important reasons for this. ELISA is a protein-
based method and qPCR is a DNA-based method- involving RNA isolation and extraction, 
and so there has been well-documented facts on the pros and cons in their use. ELISA is a 
quicker and easier method of analysis to carry out, with less tissue handling and unlike 
qPCR, which involves RNA extraction and cDNA production, which entails much more tissue 
handling and this could lead to increase of experimental errors due to technique. The qPCR 
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process however is less expensive and more specific (Adam T. Perestam, 2017). It is crucial 
to note that there have been models where the two methods have been used to express 
various proteins and not just HIF (Forooghian, Razavi, & Timms, 2007; Heward, Roux, & 
Lindsay, 2015; Liu et al., 2019; Roux, Heward, Donnelly, Jones, & Lindsay, 2017). The dual 
use of both methods has been important in the validation of results. With qPCR used to 
express the target protein, ELISA has been used to validate the level of expression in some 
studies in the literature (Dijkstra, van Kempen, Nagtegaal, & Bustin, 2014a; Lampert et al., 
2016). 
1.8 CONCLUSION 
This review has helped to highlight the problem of implant loosening due to deficient 
osseointegration seen in sickle cell disease patients. Existing literature is devoid of answers 
to this problem. Therefore, this review has shed light on the role of the hypoxic inducible 
factor (HIF) and its importance in improving osteogenesis in physiologically hypoxic 
conditions. Established literature have in the past put forward various reasons for high 
implant component loosening in these patients but there has not been any experimental 
model documented - either in vivo or in vitro which investigates this. In addition, the role of 
HIF and its effects has not been explored as a possible benefit in improving osseointegration 
in these patients.  
In an attempt to help address the gap in knowledge highlighted with regards the problem of 
component loosening seen in SCD patients, the aim of this study was to takes steps to 
develop a method that could help reduce component loosening in SCD patients.  
The first objective was to establish whether the shape of the proximal femur in these patients 
could be a factor in femoral component loosening. As part of this aim, it was important to 
identify the variation in the shape of the proximal femur in SCD patients when compared with 
those in osteoarthritic patients. 
The second objective was to develop an in vitro experimental model which may help form 
the basis for investigating osseointegration in an oxygen deprived bony environment similar 
to that seen in the marrow of SCD patients- an environment where femoral implantation 
takes place for total hip replacement. This was done by over expressing HIF. Furthermore, 
there was the need to add validity to this model, by assessing the cellular metabolic viability 
of osteoblasts cultured previously and the results could help serve as a positive indicator for 
transfer of the model to in vivo conditions. This could serve as a foundation for improving 
osseointegration in SCD patients needing THA as treatment for avascular necrosis of the 
hip. The study therefore acts as the building block needed for improved implant design 
tailored to reduce the surgical re-operating burden due to implant loosening in sickle patients 
and invariably improve their quality of life. 
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CHAPTER TWO 
RADIOGRAPHIC EVALUATION OF THE PROXIMAL FEMUR 




Avascular necrosis (AVN) is the death of bone that results in the collapse of the architectural 
bony structure, leading to joint pain, bone destruction, and loss of function (Ramos-Casals et 
al., 2002). Several underlying causes of AVN has been described. In some such as, 
proximal femur fracture, sickle cell anaemia, or decompression illness, the cause seems 
evident, while in others, such as treatment with glucocorticoids (GC) or alcohol consumption, 
the cause is not so clear. The common denominator is the femoral head liability to ischemia, 
but the pathogenic mechanism is variable. In the case of a femoral fracture, compression or 
rupture of a blood vessel is the cause of osteonecrosis (ON), while in sickle cell anaemia 
and in decompression illness, it is attributed to alterations in sinusoidal circulation (Martinez-
Ferrer, Peris, & Guanabens, 2007). 
AVN of the femoral head develops in 3-19% of patients with sickle cell disease and 
frequently this is bilateral. Sickle cell osteonecrosis is a specific entity characterised 
microscopically by diffused necrotic lesions of bone trabeculae and marrow, associated with 
an inflammatory process and new bone formation. This new apposition is responsible for 
osteosclerosis leading to a homogeneous increase of density of the head (Mukisi-Mukaza, 
Gomez-Brouchet, Donkerwolcke, Hinsenkamp, & Burny, 2011). Intravascular sickling causes 
thrombosis and then ischemia, resulting in infarcts in the femoral head, which progress to 
avascular necrosis. Chughtai et al noted in their systematic and instructional review that a 
definitive pathogenic mechanism for the osteonecrosis remains elusive (Chughtai et al., 
2017).  
Total hip replacement (THR) is therefore, indicated in such patients. It has also been seen 
that hip resurfacing arthroplasty could be successful in patients with osteonecrosis of the 
femoral head. However, various studies have shown high complication rates in these groups 
of patients who had either cemented and uncemented implants (Amstutz & Le Duff, 2016). 
Hickman et al in his study reported a 20% early revision rate in the patients who had THR. 
This was mainly due to femoral osteolysis and polythene acetabular wear (Hickman & 
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Lachiewicz, 1997). In addition, Bishop et al in his cohort group of sickle cell disease patients 
who underwent THR had a 15% revision rate mainly due to deep infection and implant 
loosening. Some theories have been put forward as reasons for this pattern, which include 
abnormal immune system, functional asplenia, and poor blood supply to bone. The reasons 
for this higher failure rate of the femoral component in many previous studies is mostly 
unknown (Tingart et al., 2009). Reported outcomes of total hip replacement in the AVN 
population have not been as good as in patients with osteoarthritis. Patients with 
osteonecrosis tend to be younger and more active than OA patients, which may account for 
some of the discrepancy (Brinker, Rosenberg, Kull, & Cox, 1996; Cornell & Ranawat, 1986; 
Ortiguera et al., 1999; Saito, Saito, Nishina, Ohzono, & Ono, 1989). Alternatively, changes in 
the bone quality in the proximal femur seen in osteonecrosis may compromise the result 
(Radl, Egner, Hungerford, Rehak, & Windhager, 2005; Radl, Hungerford, Materna, Rehak, & 
Windhager, 2005). Studies in normal patients undergoing primary hip replacements have 
shown good implant osseointegration. The average age of patients with osteonecrosis of the 
hip is 38 years. However, this patient group is at higher risk of implant failure, which may be 
due, at least in part, to their youth and activity (Lennon & Prendergast, 2001). Kim Y.H. et al 
have suggested that maintaining the mechanical integrity of the cement mantle could mean 
reducing the peak stress on the cement/bone and cement/prosthesis interfaces and this 
reduces loosening rates. They also noted in their study that there was no significant 
difference in failure rates between cemented and uncemented stems in patients with AVN 
(Y. H. Kim et al., 2011). It has been noted in a previous literature systematic review that 
there was a significant higher arthroplasty revision rate in patients with AVN secondary to 
sickle cell disease as compared with those with AVN from other causes (Johannson et al., 
2011). 
In a large series of consecutive three hundred and twelve (312) patients, aseptic loosening 
of the acetabular component occurred in 25 (8%) of the 312 hips after an average follow up 
of 13 years. Aseptic loosening of the femoral component was as common as that of the 
acetabular component. The incidence of aseptic loosening in this study with patients who 
had sickle cell disease is in contrast with the very high rate of loosening of 10% to 38% that 
has been reported in previous series with a very small number of patients and a short follow 
up (Hernigou et al., 2008). The author of this study attributed the reduction in the loosening 
rate to proximal canal filling prosthesis. Furthermore, it can be argued that the recent studies 
have shown improved revision rates and encouraging results with the use of uncemented 
implants in SCD patients. Better-designed prosthesis based on the shape of the proximal 
femur could be responsible for this.  
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There is a scientific rationale and some evidence supporting the hypothesis that the shape of 
the proximal femur is associated with compartment-specific knee OA and also it appears to 
influence the pattern of acetabular wear occurring over time (Streit, Levine, Barrett, 
Cooperman, & Goldberg, 2013; Wise et al., 2014). It has also been observed  that the shape 
of the proximal femur is an important factor in understanding the relationship between hip 
joint mechanics, gait pattern and the development of hip OA (Pedoia et al., 2018). However, 
there is no documented structural reason in the shape of the proximal femur in sickle cell 
disease patients which may cause implant loosening and hence the reason for this study in 
investigating this. It is also important to note that there is no documented pattern for the 
shape of proximal femur in these group of patients hence the need to explore this through 
this study.  
The aim of this study was to assess the variation in the proximal femoral canal anatomy in 
sickle cell disease patients and compare with similar cohort of osteoarthritic patients. 
Furthermore, the study sought to deduce if the shape of the proximal femur could have any 
bearing on the femoral component loosening rate in this group of patients which no other 
study to the best of our knowledge has established. 
 
2.1 PATIENTS AND METHODS  
 
The standardized anterior posterior radiographs of forty-two (42) sickle cell disease patients 
with degenerative hip osteoarthritis secondary to avascular necrosis and another matched 
cohort of forty-two (42) patients with primary degenerative hip osteoarthritis (OA) were 
initially taken and evaluated on a standard imaging software. Patients x-rays were taken as 
part of their routine clinical assessment for diagnosis. The study had local Research and 
Development approval and informed consent was taken from patients for their radiographs 
to be used. Both groups of patients sampled were from the indigenous local population in 
Ghana, West Africa who had presented to two local orthopaedic hospitals. The two sample 
cohorts were matched for age and gender.  
 
2.1.1 RADIOGRAPHIC MEASUREMENT PROTOCOL 
The radiographic measurements were taken using the anterior-posterior (AP) views of plain 
radiographs using a standardized X-ray imaging software, Osiri X Lite (Copyright © 2016 
Pixmeo). The lateral views were not available during the evaluation. Indices measured were 
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canal-to-calcar ratio (CC ratio) and the cortical index (CI) (Dorr et al., 1993b) (Figure 2.1). The 
CC ratio and CI (anteroposterior views) were measured using the method described by Dorr 
et al and subsequently used by other clinical researchers who have undertaken studies on the 
proximal femoral geometry. CC ratio was determined using measurements from two points on 
anteroposterior plain radiographs of the hip. These two points were established on the medial 
and lateral aspects of the medullary cavity 10 cm distal from the lesser trochanter and another 
two points are established on the medial and lateral aspects of the medullary cavity 3 cm distal 
from the center of the lesser trochanter. The CC ratio was obtained by dividing the distance X 
of the medullary cavity at the point 10 cm distal from the center of the lesser trochanter by the 
distance Y at the point at the center of the lesser trochanter. This is where the two lines formed 
by the two points on the internal aspect and the two points on the lateral aspect of the 
medullary cavity pass- X/Y (Figure 2.1). CI was determined from measurements on 
anteroposterior of the hip. This was obtained by dividing the thickness of the femoral bone 
cortex at the point 10 cm distal from the lesser trochanter (distance of the lateral aspect of the 
femoral bone cortex Z minus distance of the medullary cavity X) by the distance of the lateral 
aspect of the femoral bone cortex Z (i.e. CI= Z-X/Z). The measurements as noted-proximal 
femoral canal (Y), mid-diaphysis canal(X), extra medullary canal (Z) diameters- were made in 
centimeters (cm). The calcar-canal ratio (CC): X/Y and the cortical index (CI): Z-X/Z was 
calculated from the above measurements and the mean determined from both groups of 
patients (Al-Nasiry, Geusens, Hanssens, Luyten, & Pijnenborg, 2007; Dorr et al., 1993a; 
Merle, 2014; Nakaya, Takao, Hamada, Sakai, & Sugano, 2018). Based on the indices 
determined, the patients’ proximal femur shape was classified into three groups – A, B, C 
according to Dorr’s classification with the values of CI and CC as stated in Table 2.1 (Dorr et 
al., 1993a; Husmann, Rubin, Leyvraz, de Roguin, & Argenson, 1997; Nakaya et al., 2018). 
According to the Dorr’s description of the proximal femoral morphology- (Figure 2.2), Type A 
exhibited thick cortices that begin at the distal end of the lesser trochanter and thicken quickly, 
producing a funnel shape and a narrow diaphyseal canal. Type B exhibited bone loss 
proximally and widening of the diaphyseal canal. Type C exhibited considerable loss of the 
thickness of the cortices resulting in a wide intramedullary canal and a fuzzy appearance to 






2.1.2 OBSERVER RELIABILITY 
In order to ensure reliability of the radiographic measurements, three observers - 
orthopaedic registrar, general practitioner (GP), and medical science student were asked to 
take the above radiographic measurements independently as shown in Figure 2.1. Copies of 
this document showing the measurement protocol was made available to them for reference 
and the protocol was explained. The level of agreement using the intra-class coefficient 
(ICC) was determined for both intra-observer and inter-observer measurements. Based on 
the 95% confident interval of the ICC estimate, values less than 0.5, between 0.5 and 0.75, 
between 0.75 and 0.9, and greater than 0.90 are indicative of poor, moderate, good, and 
excellent reliability respectively (Koo & Li, 2016; Merle, 2014).The intra-observer 
measurements were taken with observers taking measurements on two separate occasions 
at least one month apart.  
STATISTICAL ANALYSIS 
Statistical analysis was carried out using the SPSS statistical software programme (SPSS 
Inc. IBM version 22). There were no previous similar comparative studies in the literature 
and so there was no representative sample sizes to compare with. However, in order to be 
pragmatic with the study, a post hoc power analysis was done bearing in mind this could be 
seen as an initial exploratory observational study.  Power calculations for the sample sizes 
was evaluated using G*power®2017: version 3.1.9.2 free to use statistical software. The 
power analysis for the SC patient sample sizes revealed that on the basis of the mean, the 
effect size observed in the study (d=1.05) and with n=42 would be needed to obtain 
statistical power of 0.99 level. Also, for the OA patient group based on the mean, the effect 
size (d=0.69) and with n=42 would be needed to obtain a statistical power of 0.88. 
Parametric tests were used to assess the normality of the data and the Welch independent 
sample t test was used to evaluate the level of significance for the cortical indices and 
calcar-canal ratios between both groups of patients. Significance level was p<0.05 unless 
otherwise indicated. Pearson correlations was used to assess linear comparable variables 
while Spearman’s rank correlation was used to evaluate the relationship between non-linear 
variables. One-way ANOVA test was used for differences in mean within and between 
groups. 
A Welch t -test was run to determine if there were differences in the calcar canal ratio (CC) 
and the cortical index (CI) between sickle cell and osteoarthritic patients due to the 
assumption of homogeneity of variance being violated as assessed by Levene’s test for 
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equality of variances (p=0.000037, p value <0.05).(Statistics, 2015a). There were no outliers 
in the data as assessed by inspection of the box plots (Figures A10 and A11). The CC and 
CI data for both patient groups were normally distributed as assessed by the visual 
inspection of the N-N Q-plots. (Figures A12-A15). The one-way ANOVA was run to 
determine if the CI in both groups of patients was different for the various Dorr’s femur types. 
Both groups of data were normally distributed. 
The Spearman’s rank order correlation was used to assess the relationship between the 
various parameters CI, CC ratio and BMI in the sickle cell group (Statistics, 2018b). 
Preliminary analysis showed the relationship to be non-monotonic as assess by the visual 
inspection of the scatter plot (Figure A16, A17). When analysing the correlation within the 
OA group, Pearson’s correlation was used as the only exception to Spearman’s in order to 
assess the relationship between age and CC ratio. The preliminary assessment showed a 
linear relationship between both variables with data showing a normal distribution as 






Figure 2.1: Plain radiography showing descriptive protocol measuring each parameter is 
shown. CC ratio: canal-to-calcar ratio; CI: cortical index  









Table 2.1- Showing Dorr’s classification of Femur Shape types based of values of Calcar 
Canal ratio and cortical index. Reference - (Dorr et al., 1993a). 
 
 A B C 
Calcar Canal- CC 
Ratio 
   < 0.57 0.59 – 0.61    > 0.62 
Cortical Index- CI 
(Anterior-Posterior 
view) 








FIGURE 2.2 Showing Dorr Types A, B, C Proximal femur morphology 
 











2.2.1: COMPARISON BETWEEN SICKLE CELL AND OSTEOARTHRITIC PATIENTS 
In the sickle cell cohort of patients evaluated, there were 29 females and 13 males.  The 
mean age was 41.5 years (range 23-68) and the body mass index (BMI) of these patients 
was 26.9 (range 18.5-45.9). (Table 2.2) The mean cortical index (CI) was evaluated as 
0.49(0.38-0.83), while the mean calcar to canal (CC) ratio was 0.47(0.27-0.89). (Table 2.3)  
For the osteoarthritic group of patients evaluated, there were 29 females and 13 males. The 
mean age was 49.5yrs (range 23-76) and average body mass index was 28.5 (range 20-
60.2). (Table 2.2). The mean cortical index (CI) was 0.64 (0.20-0.90) and calcar canal ratio 




















Table 2.2 Showing the demographic parameters for both patient groups 
SICKLE CELL  
PATIENTS 
  Range Interval Standard 
Deviation (SD) 








26.9 18.5 - 45.9 6.71 
OSTEOARTHRITIC 
PATIENTS 
   






















Table 2.3 Showing Comparison of radiographic parameters between both patient groups 





(p value <0.05) 
Dorr Type 
(Numbers) 
   
A  34 34 
B 4 5 




0.47 0.36 0.002* 
Range 
Interval 







0.49 0.64 0.00037* 
Range 
Interval 




6.71 0.20  
 











The cortical index in the SC patients mean (M) = 0.49, SD =0.09 was lower than that of OA 
patients mean (M) = 0.64, SD = 0.20, this was statistically significant p=0.00037, (p value < 
0.05) (Figure 2.3).  
The calcar canal ratio in sickle cell patients was significantly higher mean (M) = 0.47, 
standard deviation (SD) = 0.08 than that of osteoarthritic patients mean (M) = 0.36, standard 
deviation (SD) = 0.2, and this was statistically significant, p=0.002, (p value <0.05) (Figure 
2.4).  
 There was no statistically significant difference in the cortical index (CI) and calcar canal 
ratio (CC) between males and females in the SC group. (p=0.845 for CC: p value>0.05 and 
p=0.135 for CI: p value >0.05) (Table 2.3, Figure 2.3).  With regards the OA patients, there 
was a difference in the CI for males, mean (M) =0.53, SD=0.22 compared with that of 
females M=0.71, SD=0.14. (Figure 2.4). There was a statistically significant difference in the 
mean (m) = -0.18, S.E=0.07, t (16.7) = -2.71, p = 0.015 (p value <0.05) (Table 2.4) 
(Statistics, 2015a). 
For SCD patients there was no statistical difference in CI and the different femur types, 
Welch’s F (2, 4.512) =1.07, p= 0.416 (p=0.05) (Statistics, 2017a). This was the same for the 
OA group as well. There was no statistical difference in CI and the different femur types, 













Table 2.4 Showing Comparison of radiographic parameters between both patient groups 








0.51 0.48 0.135 
Standard 
Deviation (SD) 





0.46 0.47 0.845 
Standard 
Deviation (SD) 






0.53 0.71 0.015* 
Standard 
Deviation (SD) 





0.47 0.30 0.015* 
Standard 
Deviation (SD) 
0.22 0.13  
 






Figure 2.3 Shows simple dot plot of cortical index by gender and patient types (sickle 
cell/osteoarthritis) based on Dorr’s femur type. It is noted that there is more CI variability in 
the OA group. There was no statistically significant difference in the cortical index between 
males and females in the sickle cell group, p value >0.05; however, there was significant 































Figure 2.4 Shows simple dot plot of Calcar canal ratio by gender and patient types (sickle 
cell/osteoarthritis) based on Dorr’s femur type. It is noted that there is more CC ratio 
variability in the OA group There was no significant statistical difference in the calcar canal 
ratio between males and females in the sickle cell group p value >0.05; however, there was 


















Dorr femur type    
A 34 0.50 0.06 
B 5 0.49 0.62 










Dorr femur type    
A 34 0.64 0.20 
B 4 0.76 0.10 
C 4 0.47 0.22 
Significance (p 
value <0.05) 
p = 0.14  













For the sickle cell disease patients, there was no statistically significant correlation between 
the CC ratio and BMI, r (40) = - 0.159, p = 0.315 (p>0.05), two tailed (Table 2.6). It was also 
noted that there was no statistically significant relationship between CI and BMI, r (40) = 
0.048, p=0.776 (p>0.05), two tailed. However, there was significant correlation between age 
and the BMI of SC patients, r (40) = 0.35, p=0.023 (p<0.05), two tailed (Table 2.6). 
With regards the correlations for the OA group, there was a statistically significant positive 
correlation between age and CC, r (40) = +0.518, p=0.0004 (p<0.01), two tailed. (Table 2.7) 
(Statistics, 2018b). There was also a statistically significant negative relationship between CI 
and age, r (40) = - 0.51, p= 0.001 (p<0.01), two tailed. It was also seen that there was a 
statistically significant correlation between BMI and age, r (40) = 0.352, p=0.022 (p<0.05), 
two tailed. (Table 2.8) 
 
Table 2.6 Showing Spearman’s correlation between Age and BMI with radiologic 
parameters deduced in Sickle Cell group. 
 Correlation (rho) Significance (2-tailed)  




Age vs Cortical Index 
(CI) 
0.038 0.809 




Body Mass Index vs 
Calcar canal ratio 
 
-0.159 0.315 










Table 2.7 Showing Pearson’s correlation between Age and Calcar Canal ratio in 
Osteoarthritic patient group 
 
 Correlation (rho) Significance (2-
tailed) 





**Correlation is significant at 0.01 level (2-tailed) 
 
Table 2.8 Showing Spearman’s correlation between Age and BMI with radiologic 
parameters deduced in Osteoarthritic patient group. 
 
 Correlation (rho) Significance (2-tailed)  
Age vs Cortical Index 
(CI) 
0.51 0.001** 




   
Body Mass Index vs 
Calcar Canal ratio 
 
0.127 0.423 





** Correlation is significant at the 0.01 level (2-tailed) 






2.2.1 LEVEL OF AGREEMENT AMONGST OBSERVERS  
INTRAOBSERVER RELIABILITY 
The intra-observer Intra-class correlation coefficient (ICC) was found to be excellent among 
all three observers across all the radiographic measurements in both cohorts of patients 
ranged from 0.89 to 0.99 (p value <0.001). 
INTEROBSERVER RELIABILITY  
The inter-observer reliability data showed excellent agreement amongst observers in all 
radiographic measurements in the sickle cell cohort, range 0.91 to 0.99, p value <0.001 and 
there was moderate to excellent agreement amongst observers in the osteoarthritic cohort in 




2.3 DISCUSSION  
 
This radiographic study had the objective of confirming or refuting the hypothesis that the 
variation in the shape of the proximal femur maybe responsible for femoral implant loosening 
in sickle cell disease patients with total hip arthroplasty. Clark et al noted in their cadaveric 
study that the normal shape of the proximal femur is variable, and variations in the absence 
of intrinsic bone disease appear to reflect adaptation to physiologic variations in the line of 
action of muscle forces (Clark, Freeman, & Witham, 1987). In view of this, Bahari et al in 
their study attempted the prediction of shape and internal structure of the proximal femur 
using a modified level set method for structural topology optimisation (Bahari, Farahmand, 
Rouhi, & Movahhedy, 2012). It could be said that these variations in the shape of the 
proximal femur can be seen in various pathologic conditions but established literature has 
little of this information. Hammer et al determined that the forces acting through these 
trabeculae on the proximal femur can affect its overall shape and configuration in its coronal 
plane (Hammer, 2002). However, this study did not present any evidence concerning the 
relationship between variations in femur shape and pathology. There are studies however 
that observed these structural variations in the proximal femur and have proposed that this 
helps in assessing the risk of osteoporosis and fragility fractures (Gregory et al., 2004; 
Lindner et al., 2015). The results from this study though not an autopsy nor finite modelling 
assessment like previous studies cited above, suggests a similar pathologic risk. It was 
deduced from this work that most of the patients in the SCD cohort had Dorr’s type A 
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proximal femur funnel shape but less so when compared with OA patients (Table 2.3).  It 
was also noted that there was lower cortical index than that seen in OA patients meaning 
thinner cortices in sickle cell patients. The combination of these two findings could suggest 
an increased risk of periprosthetic fractures and loosening with the use of uncemented 
implants as documented in recent studies (Ilyas et al., 2018). There is no evidence in 
documented literature that objectively correlates the risk of implant loosening in SCD 
patients who have had THR with the shape of the proximal femur. However, there could be a 
case in our findings with OA patients having more funnel shaped femurs allowing for more 
press fitting femoral implant fixation with the use of uncemented prosthesis. The outcome of 
the largest series of SCD with cemented THR showed very promising results with low failure 
rate of the femoral component compared to other series in the literature. The authors 
ascribed this to the “French Paradox Technique” - where  rectangular medullary canal filling 
femoral prosthesis (without obtaining continuous cement mantle) was used allowing for 
direct load transfer to bone by close cortical contact (Hernigou et al., 2008). It could 
therefore be postulated that this was possible due to the geometry of the proximal femur of 
these SCD patients as seen in this study.  The less funnel shaped femurs seen here when 
compared to OA patients (Table 2.3) could be a contributing factor to allowing this technique 
to be used in the large series earlier described and hence the low implant failure rate.    
Some studies have been able to support the relationship between the development of 
disease pattern of hip osteoarthritis and the shape of the proximal femur (Lindner et al., 
2015; Radl, Egner, et al., 2005). However, the question on whether the shape of the 
proximal femur has a causative role in the development of implant loosening still needs 
answers and this study sheds some light on this.  In this cohort of patients who are all black 
Africans, it was observed that the average cortical index was marginally higher indicating 
higher cortical thickness, bone strength and increased trabecular bone mineral density. This 
finding is similar to conclusions noted by Marshall L.M. et al in their study of the race and 
ethnic variation in proximal femur structure (Marshall et al., 2008). The afore mentioned 
parameters should negate implant loosening but this may not be the case in SCD patients 
with THR. The evaluation deduced in this study noted that there was no significant difference 
in the cortical indices and the types of femur shapes in both groups of patients (Table 2.5). 
However, this is in contrast to previous radiologic studies (Jennings, Thiele, & Krynetskiy, 
2016; Nakaya et al., 2018). It is also worth noting that because of the lack of clear difference 
in the CI of the various types of femur shapes in the evaluation of the SC patients, it could be 
difficult to predict the risk of periprosthetic fractures and so invariably leading to implant 
loosening. This is in contrast to other studies relating cortical thickness to this risk (Nash & 
Harris, 2014). It is also important to note from this study that there was no relationship 
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between age and CI, CC in the sickle cell group (Table 2.6). This finding is also in contrast 
with other findings in the literature (Dorr et al., 1993a; Dorr, Wan, Song, & Ranawat, 1998; 
Tsubosaka et al., 2018). However, in the OA group with the increase in age, there was 
increase in CC (Table 2.7) meaning that older patients had less funnel shaped femurs. 
Furthermore, it was confirmed that with the increase in age in the OA group, there was 
decrease in the cortical thickness. These correlation findings were the opposite in the sickle 
cell disease group and so it would be accurate to suggest that SCD patients’ femur shape 
may not follow established known physiologic patterns. 
Dorr et al observed in his study that patients with high cortical index and lower calcar canal 
ratio have funnel shaped proximal femurs which is suitable for press fit implant fixation (Dorr 
et al., 1993b). The assessment deduced from this study of the radiographs of SCD patients 
establishes this finding as well but it still leaves questions about the reason for high implant 
failure in these patients unanswered. The mean age of patients in this study is similar to 
previous studies, which show a younger age group, and various observers have highlighted 
the level of activity as a major cause of implant failure in this group of patients (Dudkiewicz 
et al., 2004; Hernigou et al., 1993). However, Radl et al in their study involving a similar 
number in his cohort of patients as ours, showed that patients with total hip arthroplasty after 
AVN of the femoral head associated with a systemic disease (steroid medication, alcohol 
abuse and sickle cell disease) are at higher risk of implant failure compared with patients 
with idiopathic or post-traumatic osteonecrosis. They suggested that the higher failure rates 
after total hip arthroplasty in patients with osteonecrosis of the femoral head associated with 
a systemic disease might be related to abnormal bone quality. This is probably accelerated 
by the higher mechanical demand in this young patient population (Radl, Egner, et al., 
2005). The results of our study support this view, with lower CI and less funnel shaped 
femurs in our sickle cell group. However, recent series have confirmed that there has been 
no difference in implant survival and failure rate between patients who had THR with AVN 
from SCD and those who had the same procedure due to osteonecrosis from other causes 
(Issa et al., 2013). There is however no objective scientific study in SCD patients proving this 
hypothesis. This study sheds light on the fact that the shape of the proximal femur in these 
patients is ideal for implant fixation and does not answer the prevailing question of why the 
high rate of implant loosening which may be from lack of osseointegration. However, it was 
also noted in this study that the SCD cohort of patients had a higher cortical index and lower 
calcar canal ratio as compared with other published cohorts of Caucasian osteoarthritic 
patients in the literature (Dorr et al., 1993b; Marshall et al., 2008). When comparing the 
cortical index and calcar canal ratio in the SCD group with that in the OA group in this study, 
it was noted that there was a slight discrepancy with significantly higher CC ratio in the SC 
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group meaning more funnel shaped proximal femur in the OA group. Furthermore, this study 
may suggest that African patients have more funnel shaped femurs as compared to 
Caucasians studies in the literature.   
 
To the best of our knowledge there are no other previous studies looking at this radiologic 
comparison between SCD proximal femur and that of OA patients. This can be seen as the 
strength for this work but we are aware that this study has limitations. The low sample size 
may only allow for significant postulations to be made and not definitive conclusions. Our 
study only had forty-two patients compared to other studies with greater sample sizes (Dorr 
et al., 1993a; Jennings et al., 2016; Nakaya et al., 2018; Nash & Harris, 2014; Tsubosaka et 
al., 2018). The measurements from which the cortical indices were calculated, was from 
anterior posterior plain x-rays views only as the lateral views were not available for the study 
due to health care expenses as patients still largely pay for healthcare cost in the host 
sample country (A. George & Ofori-Atta, 2019; A. O. George & Ofori-Atta, 2009). This did not 
allow for lateral view verification of the cortical index in these patients. Measurements were 
also taken on non-digitalized x-ray views, which could impair on the accuracy of 
measurements (Figure A1). The use of CT scan images would have conferred more 
accuracy to the measurements taken (Hoenecke, Hermida, Flores-Hernandez, & D'Lima, 
2010; Wines & McNicol, 2006). Furthermore there were no objective outcome measures in 
the form of post-operative radiographs which allows for femoral stem fixation assessment for 
loosening using the Charnley and Gruen methods for cemented (Gruen, McNeice, & 
Amstutz, 1979) and the Engh method for uncemented prostheses (Engh, Massin, & Suthers, 
1990). Although there were three observers for the radiographic measurements’ reliability 
validation, one of the observers was a university medical student, the others were a general 
practitioner and another an orthopaedic registrar. The observer variability could have an 
impact on the measurements taken from the plain x-rays. (Hanley et al., 2017) (Tables A4-
A6). 
 
It is clear that these SCD patients do have funnel shaped proximal femurs and hence 
implant sizing maybe an issue as experienced in these patients and further causing 
intraoperative periprosthetic fractures. Custom designed implants are already being used in 
hip arthroplasty of patients with congenital dysplasia of the hip (Koulouvaris, Stafylas, & 
Xenakis, 2008). As the standard of care and life expectancy of sickle cell disease patients 
improves, the need for optimal results in those needing hip arthroplasty is crucial. This study 
highlights the different femoral shape geometry in these patients, and so appropriate implant 
use and design for them cannot be overlooked.   
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2.4 CONCLUSION  
 
According to Dorr classification of types of variations in proximal femoral anatomy, x-ray 
measurements showing higher calcar to canal ratios, suggesting less funnel shaped 
proximal femurs in sickle cell disease patients compared with non-sickle cell OA patients. 
This is clearly seen in the above measurements determined in this sample of sickle cell 
disease patients. However, when compared to OA patients, SCD patients had significantly 
thinner cortices. It is therefore suggested that this could influence femoral stem fixation and 
increase risk of periprosthetic fractures leading to more stem failures. The results therefore 
imply that the structural anatomy of these patients’ proximal femurs could contribute to 
implant loosening. It can be concluded that sickle cell disease bone does not follow the 
normal physiologic trend of decreasing cortical thickness with age and this would be useful 
to surgeons when carrying out hip replacements in these patients. This study though with its 
limitations, highlights that the funnel shaped proximal femur with diminished cortical 
thickness seen in these group of patients makes the case for needed intra operative 
precautions in sickle cell patients with AVN having hip arthroplasty. Properly designed 
prospective studies of SCD patients with THR from AVN together with in vivo and in vitro 
research models could help highlight other factors that could answer the question of 
















EXPERIMENTAL STUDY TO INVESTIGATE A POTENTIAL 
MODEL FOR IMPROVED OSSEOINTEGRATION IN SICKLE 




Having established in the previous chapter that the structural anatomy of the proximal femur 
in sickle cell disease patients may have some basis in the cause of femoral stem prosthesis 
loosening, then there could also be some truth in the lack of implant osseointegration in 
these patients which could be another contributing factor to femoral stem loosening. It would 
be important to establish a model to help investigate the enhancement of this physiologic 
phenomenon. 
Sickle cell disease (SCD) is an inherited blood disorder characterized by adherent, rigid, 
abnormally shaped erythrocytes that occlude blood vessels and compromise blood and 
oxygen supply to tissues and organs. ‘‘Hypoxemia,’’ which is due to decreased arterial blood 
oxygen content, decreased oxygen carrying capacity due to chronic anaemia, and 
oxyhaemoglobin desaturation, is a well-documented phenomenon in patients with SCD 
(Caboot & Allen, 2014). Studies have shown that hypoxia in these patients leads to higher 
incidence of vasocclusive crisis (Setty, Stuart, Dampier, Brodecki, & Allen, 2003). Although 
vasocculsion can be seen in any organ in the body, it is common in the bone marrow 
because of marrow hyper cellularity leading to impaired blood flow and regional hypoxia, 
which is chronic (Almeida & Roberts, 2005). This cascade of events causes avascular 
necrosis which is the bony environment in which hip femoral prosthesis are implanted in 
sickle cell disease patients. In a study where longitudinal prospective controlled evaluation of 
magnetic resonance imaging (MRI) of long bones in sickle cell patients was done, it was 
concluded that the increased severity of patchiness of the long-bone MRI in older patients 
with SCD was a result of recurrent sickling with progressive, perivascular fibrosis in the 
marrow (Mankad et al., 1990). 
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Despite the above, the role of the hypoxic inducible factor (HIF) in these patients has been 
called into question. Recent studies show that HIF and Hypoxic mimicking agents (HMA) 
trigger the initiation and promotion of angiogenic-osteogenic cascade events. In vitro and 
animal studies involving genetic manipulation of individual components of the HIFs and 
HMAs have provided clues to how angiogenic-osteogenic coupling is achieved. This 
foundational work is important in understanding the therapeutic basis of bone regeneration 
and repair (Mamalis & Cochran, 2011). However, there has been paucity of studies 
investigating how HIF could be over expressed under chronic hypoxic conditions akin to that 
seen in sickle cell disease patients to help form a template for tackling the matter of macro 
cellular avascular necrosis. Angiogenesis and osteogenesis are tightly coupled during bone 
development and regeneration, and the hypoxia-inducible factor-1 alpha (HIF-1) pathway 
has been identified as a key component in this process studies have shown (Wan et al., 
2010). There are still no established experimental models showing how this knowledge can 
be used for the evaluation of bone implant integration and hence suggest ways of improving 
osseointegration in sickle cell disease patients with hip arthroplasty, thereby preventing 
increased implant loosening.  
It is fair to say some experimental models have looked at osseointegration in which the 
concept of hypoxia has been modulated in relation to this phenomenon (Maes et al., 2012), 
but no in vitro models in the literature have be able to mimic similar hypoxic environment in 
pathologic bone conditions such as SCD. Establishing such in vivo models in animals can be 
difficult because SCD is also a genetic abnormality whose sequelae is chronic bony hypoxia 
and this can be an uphill task mimicking this in animal models. Some research framework 
models set up hypoxic cultures over long periods in some cases up to 21 days (Ren et al., 
2006) and this reduces the differentiation potential of the cells especially when mesenchymal 
stem cells are used (Czekanska, 2011). In view of these pitfalls, we aim to propose a model 
that would not require such long durations to achieve experimental results and plan to use 
cell lines that are rapidly growing such as MG63 osteosarcoma cells. (Heremans et al., 
1978). 
This study seeks to create an experimental model to help establish the role for the over-
expression of HIF in enhancing osseointegration. The model proposed is aimed at mimicking 
true hypoxia in vivo and cells cultured in the presence of cobalt chloride (CoCl2) grow in a 
simulated hypoxic micro- environment. CoCl2 is a hypoxia-inducing agent because Co
2+ 
replaces Fe
2+ in haemoglobin, forming deoxygenated haemoglobin and it inhibits HIF-lα aryl 
hydrocarbon-hydroxylase activity to reduce HIF-lα degradation. Therefore, the features of 
CoCl2 simulated hypoxia are similar to those of the in vivo hypoxic microenvironment (B. 
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Zhang et al., 2013). It is important to note that the introduction in the use of Cobalt chloride 
suggested here in this model should not contradict the current views held in the scientific 
literature on the adverse reaction to metal debris (ARD). This is because of the use of metal 
on metal or hip resurfacing implants leading to perivascular lymphocytes aggregates with 
follicles of B and T cells, tissue necrosis, fibrin exudation, endothelial venules and 
accumulation of macrophages. Due to these adverse biological reactions, the Medical and 
Healthcare Products Regulatory Agency (MHRA) issued a safety alert in April 2010 and this 
led to a recall of patients, revision surgery for patients and increased surveillance of patients 
involving blood metal ions testing annually and cross-sectional imaging (Hart et al., 2011; 
Matharu, Judge, Pandit, & Murray, 2018). Blood metal ions of cobalt or chromium should not 
be greater than 7 parts per billion as this is associated with significant soft tissue reactions 
and failure of metal and metal hips (Benelli, Maritato, Cerulli Mariani, & Sasso, 2019). With 
this in mind, the use of cobalt chloride here will be as a hypoxic mimetic for the in vitro 
research model, needed for the expression of HIF and concerns about causing 
arthroprosthetic cobaltism would be negligible. 
With the propagation of HIF in hypoxic conditions, the osteogenic bony tissue under these 
conditions, may have the metabolic and viability potential useful in the physiologic process of 
osteogenesis. This experimental study aims to answer this question. It is envisaged that the 
results seen here may add to the body of studies which could serve as a foundation for 
experimental research modelling in decreasing the incidence of implant loosening and the 
overall hip surgery revision burden seen not only in sickle cell disease patients with total hip 
replacements but also in the wider hip arthroplasty patient community. 
 




Cell passaging and Culture Analysis 
 
MG63 human osteosarcoma cells (Sigma Aldrich) were cultured in media composed by 
volume of 87% Dulbecco’s Modified eagle medium (GlutaMax-1) DMEM-(Gibco Life 
Technologies):  10% Foetal Bovine Serum (FBS)- Sigma:  1% Non-essential Amino-acid 
(NEAA) 100x-(Sigma Life Science): 1% Penicillin-Streptomycin (P/S)- (Sigma Life Science): 
1% Sodium Pyruvate (NaPy) - (Sigma Life Science). 
Cell passaging was done with the MG63 cells previously cultured under normoxic conditions- 
as follows; Cell culture media was aspirated from T75 ml  culture flask (Appleton Woods) . 
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Aspiration was through an aspiration pipette (VWR) which was connected to an aspirator 
pump (KNF Neuberger). 5mls of Phosphate Buffered Saline(PBS) - ( Sigma Life Science) 
was then added to the well to wash the cells and then carefully aspirated away. 5ml of 
Trypsin/EDTA solution (Sigma Life Science) was added to the culture flask and then placed 
in an incubator (Wolf Laboratories) at 37 degrees and 5% CO2 for 5 minutes. This was done 
inorder to detach the cells from the culture surface in the flask. Once detachment was 
ascertained under the light microscopy (Nikon Eclipse TS100 Light Microscope) at 100x 
magnification, then 10ml of culture media which was intially constituted was then added and 
total voulme transferred to a 50 ml centrifuge tube (Fisher) and centrifuged (DJB Labcare 
Centrifuge machine) at 1000g for 5 minutes duration. 
Once this was done, the supernatant was aspirated leaving the residual cell pellet which was 
then broken by adding 5 ml of cell media which was then sucked up and down the pipette 




50μl of the above mixture cell solution is mixed with an equal volume of  trypan blue stain 
(Gibco Life Technologies). Then 10 microliter of this mixture was applied on a 
haemocytometer fast read slide (Una Health) which was then placed under the light 
microscope at 10x magnification and then viable cells were manually counted using the a 
handheld counter tally (Fisher). The fast read haemocytometer slide has  grid squares seen 
under the light microscope and each grid contains 3x3 small squares and viable cells within 
this a grid is counted as described above. Cells which were non-viable ( those through which 
trypan blue dye had penetrated their cytoplasm ) now stained blue were excluded from the 
count. Three to five sample counts were done and the mean cell number was determined. 
Cell concentration was then determined  using equation 3.1 
 
Cell concentration( (cell number/ ml) =  Cell count  X   dilution factor     X   10,000(ml) 
                 for Trypan blue (2) 
 




From the cell concentration calculated, then the volume of cell solution was then determined 
in order to yield the required number of cells to be seeded into each well in a six well culture 
plate based on the well surface area for cell attachment. 
 Cells were seeded into 6-well plates in cell media with and without Cobalt Chloride (CoCl2) 
at 100,000 cells per well and cultured under two conditions (normoxic and hypoxic) in the 
incubator - 20% and 1% oxygen. 3µl of 300mM of Cobalt Chloride solution (Cobalt Chloride 
CoCl2-(3mM)-University of Bath) was introduced into the experimental samples. The 
normoxic cells without CoCl2 were used as the control samples. Normoxic samples were 
incubated in the CO2 Incubator-(RS Biotech-Model No. 170-200, Copyright 2006) while the 
incubation for the hypoxic samples was in the Galaxy R CO2 Incubator- (RS Biotech-Model 
No. 170-300, Copyright 2006). The incubation period for the cells was 48 and 72 hours. Cell 
cultures were grown three times (n=3)  on three separate consecutive occasions (N=3) 
(Taylor, Wakem, Dijkman, Alsarraj, & Nguyen, 2010)  at 48 hours and 72 hours separately – 
under the following conditions- 20% normoxia with and without cobalt chloride: 1% hypoxic 
conditions with and without cobalt chloride. Cobalt Chloride introduced to each well was 
used to enhance intracellular hypoxia (B. Zhang et al., 2013). All equipment and containers, 
tubes, pipettes were disinfected with 70% Ethanol solution before being used in the Biohood- 
Microflow Advanced Biosafety Cabinet (Astec Microflow) to ensure sterility. There was no 




Applied Biosystems StepOne Plus TM Real Time PCR Sytem Thermal Cycling Block (S/N-
272004532)- (Applied Biosystems-Copyright 2010) was used for the  qualitative polymerase 
chain reaction step: The VeritiTM Thermal Cycler (Applied Biosystems 2010) was used for the 
complementary DNA (cDNA) synthesis step: Synergy HT Multi-detection Microplate Reader-
(BioTEK Instruments Inc.-Copyright 2006) with the Microplate Data Collection and analysis 
software-(BioTEK Instruments Inc.-Copyright 2006- 2008) was used for both the alamar blue 
assays and the picogreen assays in subsequent studies. 
The Galaxy R CO2 Incubator- (RS Biotech-Model No. 170-300, Copyright 2006) was used to 
incubate cell cultures under hypoxic conditions while the CO2 Incubator- (RS Biotech-Model 
No. 170-200, Copyright 2006) was used for cell cultures under normoxic conditions :Laminar 





96- well fast thermal cycling plates 
MicroAmp™ Optical Adhesive Film (Thermoscientific) and MicroAmp plates 
(Thermoscientific) were used to place the synthesized complementary deoxyribonucleic acid 





3.3.1 Ribonucleic acid (RNA) Isolation and extraction 
Once cells were incubated under the specified periods- 48 and 72hours, they were washed 
with 1ml of PBS solution per six well plate. Cell lysis was carried with addition of 600 
microliters of RLT lysis buffers per well. The total RNA isolation and extraction was done 
using the Qiagen RNeasy kit which included an on-column DNase treatment- process which 
was according to the normal Qiagen RNeasy protocol (QIAGEN, 2012). This was as follows 
- 1 volume of 70% ethanol was added to equal volume of lysate obtained above in each well. 
The samples were then transferred to the shredder column and centrifuged for 15 seconds 
at 10,000 x g and the flow through solution was then placed in the RNeasy Mini spin column. 
It was then placed in a 2ml collection tube supplied in the kit. This was now centrifuged for 
15 seconds at 10,000 x g. The flow through solution was discarded. Then 350μl of RW1 
buffer was transferred into the RNeasy column and the lid was closed and centrifuged for 15 
seconds at 10,000 x g, the flow through was then discarded. 10μl of DNase 1 stock solution 
was added to 70μl of Buffer RDD. This was mixed gently by inverting the tube and the 80μl 
DNase incubation mix was added directly to each RNeasy column membrane and placed on 
the benchtop (at 20-30ºC) for 15minutes. Once this time had elapsed, 500μl buffer RPE was 
added to the RNeasy column and centrifuged for 15 seconds at 10,000 x g after which the 
flow through was discarded. The above step was repeated but this time the RNeasy column 
was centrifuged for 2 minutes. The RNeasy spin column was then placed in a new 2ml 
collection tube (supplied in the kit) and then centrifuged at full speed for 1 minute to dry the 
membrane. Subsequent to this, the RNeasy spin column was now placed into a new 1.5ml 
collection tube and then 30μl RNase free water was added directly to the spin column 
membrane. This was kept on the bench top for 1 minute and then the column spin tube was 





3.3.2 RNA quantification. 
 
RNA quantification was done using the Qubit method - ( Qubit 2.0 -Life Technologies) 
according to manufacturer’s protocol (Technologies, 2010).This was done to ascertain the 
concentration of RNA in each sample and was as follows- two assay tubes for the standards 
were set up and labelled while one tube for each user sample RNA was set up and labelled 
as well. The qubit working solution was prepared by diluting the Qubit reagent (provided in 
the kit) 1:200 in Qubit buffer. 200μl of working solution for each standard and sample. The 
assay tubes were prepared according to the table below.  All assay tubes were vortexed for 
2-3 seconds once samples are prepared. The tubes are then inserted into the QubitTM 
Fluorometer and RNA quantification readings are taken (Technologies, 2010). 
 
  
Table 3.1 shows the volume composition for RNA quantification using the Qubit 
method. (Technologies, 2010) 
      
     Standard assay tubes  Sample assay tubes 
 
Volume of working solution    190μL        198μL 
_____________________________________________________________________ 
Volume of standard to add   10μL           - 
_____________________________________________________________________ 
Volume of sample RNA      -           2μL 
_____________________________________________________________________ 














3.3.3 Complementary Deoxyribonucleic acid (cDNA) synthesis  
 
cDNA was synthesized using the High Capacity cDNA Reverse Transcription kit 
(Biosystems, 2006). First of all, the reverse transcription (RT) master mix was prepared on 
ice using the components in the kit as described. A mixture of the following was carried out 
2.0μL of 10X RT Buffer: 0.8 μL of 25X dNTP Mix (100mM):2.0 μL of RT Random Primers: 
1.0 μL of Multi-Scribe Reverse Transcriptase: 1.0 μL of RNase Inhibitor: 3.2 μL of Nuclease -
free water. Once this master mix was prepared then 10 μL of the mix was pipette into each 
cDNA tube and then 10 μL of RNA sample was transferred into each tube and pipetting up 
and down twice to mix. The tubes lids were then closed and then centrifuged briefly to spin 
down the contents and to eliminate air bubbles. The tubes were then placed into the Applied 
Biosystems VeritiTM Thermal Cycler- Copyright 2008 for the cDNA synthesis. 
 
3.3.4 Reverse Transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR) 
Quantification 
Hypoxic Inducible Factor 1alpha (HIF1 alpha) was used as the experimental gene while 18S 
and GAPDH were used as the house keeping genes. The coding of the respective primers 
was as follows-.  
Primers- 
Hypoxic inducible Factor 1-alpha (Forward and Reverse)-(Sigma Life Science)- with 
sequence 5’ 
-AAAGAGGTGGATATGTCTGG (forward); AGTTTGTCTGTCGTTGCTGC (reverse) 
 
18s (Forward and Reverse)-(Sigma Life Science)-  with sequence 
-AAACGGCTACCACCACATCGAAG (forward): CCTCCAATGGATCCCTCGTTA (reverse) 
 
GAPDH (Forward and Reverse)-(Sigma Life Science)-  with sequence 
-AAGGTGAAGGTCGGAGTCAAC (forward): GGGGTCATTGATGGCAACAAT (reverse) 
 
Expression of HIF1 alpha ,18s and GAPDH RNA was determined by qRT-PCR using the 
SYBR_ Green PCR mix (Applied Biosystems) and cycle threshold (Ct) values were 
generated using the Applied Biosystems Step-One plus TM Real Time PCR System Thermal 
Cycling Block (S/N-272004532)-Applied Biosystems-Copyright 2010. The Ct value is defined 
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as the number of cycles required for the fluorescent signal to cross the threshold (i.e. 
exceeds background level). Ct values are inversely proportional to the amount of target 
nucleic acid in the sample (i.e. the lower the Ct value the greater the amount of target 
nucleic acid in the sample). Ct value of < 29 are strong positive reactions indicative of 
abundant target nucleic acid in the sample. Ct values of 30-37 are positive reactions 
indicative of moderate amounts of target nucleic acid while Ct values of 38-40 are weak 
reactions indicative of minimal amounts of target nucleic acid which could represent an 
infection state or environmental contamination (Beltrame, Cortes, Bandeira, & Figueiredo, 
2015; Khan, Choong, Du, & Jovanovi'c, 2013).  
 In order to quantify gene expression for HIF 1 alpha by quantitative reverse transcriptase 
polymerase chain reaction (qRT-PCR), the 18S and GAPDH values were used to normalize 
the data. The separate well 2(Delta-Delta Ct) method was used to determine relative fold 
change expression of HIF 1 alpha. This was normalized to 18S and GAPDH.  
 
3.3.5 Statistical Analysis 
 
Microsoft Excel software version 2016 (Microsoft Inc. Copyright 2016) was used to store and 
collate the data. Statistics analysis was carried out by using SPSS statistical software 
(version 24-IBM Cooperation Copyright 1989, 2016). The data, which was non-parametric, 
was analyzed and differences between the groups ascertained using Kruskal- Wallis H 
(KWH) test as assumptions for a one -way ANOVA were not met. The data was expressed 





From the results analysed it was clear that there was increased expression of HIF1-alpha 
using quantitative polymerase chain reaction (qPCR) at 72hours as compared to 48hours (p 
value<0.05) under the various conditions (Figure 3.1). The KWH test was conducted to 
determine if there were differences in the fold change  of HIF between 48 hours and 72 
hours. The distribution of the fold change were not similar as assessed by visual inspection 
of the boxplot. The level of expression of HIF increased from 48hrs (mean rank= 4.60) to 
72hrs (mean rank =5.60) but this difference was not statistically significant, X2(1) = 0.24, p 
=0.625. This means that expression of HIF could be affected by the increased duration of 
sample culture. 
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 When the level of expression of HIF was assessed against the control reference samples of 
normoxia without CoCl2, it was noted that there was significant level of expression of HIF at 
72 hours duration as compared to the level of expression at 48 hours (Figure 3.2). This 
observation is consistent with the previous assertion of increased expression at 72 hours 
versus that seen in 48 hours. 
It was also explored if there was a difference in the expression of HIF between the normoxic 
and hypoxic samples. Furthermore, at 48 hours’ duration, it was observed that there is 
decreased expression of HIF between the test samples (hypoxic) when compared with the 
normoxic samples with or without cobalt chloride (Figure 3.2). This trend was noted to be 
different when the 72hours samples were observed. Here there was increased expression of 
the test gene HIF in the hypoxic samples when compared with normoxic samples whether or 
not they had CoCl2 (Figure 3.3). We then checked if there was a statistical significance in the 
HIF expression between hypoxic and normoxic samples using the KWH test. The values of 
mean ranks are noted in Table 3.1. Distribution of the fold expression data was not similar 
for both types of samples as confirmed by the visual inspection of the boxplots. The mean 
rank fold change of HIF in hypoxic samples decreased compared to the normoxic samples 
but this difference was not statistically significant, X2(1) = 0.54, p= 0.462. Therefore, the 
expression of HIF is only increased with prolonged hypoxia as seen in the 72 hour samples. 
The expression of HIF in samples with cobalt chloride was seen to be higher than samples 
without (Figures 3.1 and 3.3). The distribution for the expression of HIF in samples with and 
without CoCl2 were similar as confirmed by the appearance of the box plots. The expression 
increased in samples with CoCl2 (mean rank=5.17), compared with samples without CoCl2 
















Table 3.2  Showing the mean rank of fold change expression of HIF under the various 
sample conditions noted- with and without cobalt chloride, hypoxic or normoxic samples, 
durations of sample culture (48hrs or 72hrs), and type of  reference gene. The significance 
difference between samples was assessed using the Kruskal Wallis H test as assumptions 
were not met for ANOVA. The mean rank scores were used to assess for level of 
significance because  the distribution scores for the fold change for the various parameters 




PRESENCE OF COBALT CHLORIDE 
(CoCl2) 
 





 (p value< 0.05) 





TYPE OF SAMPLE   
Normoxic sample-20% oxygen 
 
5.60 0.462 
Hypoxic sample-1% oxygen 4.25  
   
DURATION OF SAMPLE CULTURE   
48hrs 4.60 0.624 
72hrs 5.50  
REFERENCE GENE USED 
 
  
18S 4.25 0.773 














Figure 3.1 : Shows increased fold change expression of HIF over 72 hours as compared to 
48 hours. Mean rank scores confirmed increase but this was not statistically significant p 
=0.625, p value (>0.05) . The above data was the S.E.M. of three independent 













Figure 3.2: 48 hours’ fold change- graph of expression of HIF compared with control. This 
shows decreased expression of HIF when compared with the reference control. There is 
decreased expression of HIF between the test samples - hypoxia (1%) with Cobalt Chloride 
(COCl2) when compared with the hypoxic (1%) without Cobalt Chloride (COCl2) samples. 
There was no statistically significant difference in the mean rank fold change expression of 
HIF between the normoxic and hypoxic samples with or without CoCl2, p value > 0.05. The 
above data was the S.E.M. of three independent measurements on three separate 




















































FIGURE 3.3: 72 hours’ fold change- graph of expression of HIF compared with control. This 
shows increased expression of HIF of test samples hypoxic (1%) with Cobalt Chloride 
(COCl2) when compared with the reference control. Mean rank score test did not show any 
statistically significant difference p = 0.462, p value (<0.05). The above data was the S.E.M. 








































Analysis was done comparing the expression of HIF against the various housekeeping 
genes -18S and GAPDH. It was noted that there was more expression of HIF with 18S as 
compared with GAPDH at 48hours with the normoxic and hypoxic samples with CoCl2 but 
with the hypoxic samples with Cobalt Chloride using GAPDH, there was decreased 
expression compared with the reference. (Figure 3.4). The reverse was the case at 72 hours 
with increased expression of HIF with the hypoxic samples with COCl2 compared with similar 
normoxic samples (Figure 3.5) at 72 hours’ samples expressed HIF more against GAPDH 
samples when compared to 18s samples. However, there was no statistical difference in the 
level of expression of HIF between the samples with different reference genes, X2(1) =0.083, 




Figure 3.4: Fold Change of HIF compared to that seen in housekeeping genes (18S and 
GAPDH) after 48 hours of incubation. There was increased expression of HIF with 18S as 
housekeeping gene when compared to the control and GAPDH across both norxmoxic and 
hypoxic samples with CoCl2. The mean rank differences was not statistically significant, p 
value > 0.05. The above data was the S.E.M. of three independent measurements on three 



























Figure 3.5  Fold Change of HIF compared to that seen in housekeeping genes (18S and 
GAPDH) after 72 hours of incubation. There was increased expression of HIF with GAPDH 
as housekeeping gene when compared to the control and 18S across both norxmoxic and 
hypoxic samples with CoCl2.  Mean rank score had a p value >0.05, showing no significant 
difference. The above data was the S.E.M. of three independent measurements on three 




































Osteonecrosis of the femoral head (ONFH) is a prevalent complication of sickle cell disease 
(SCD) that has not been well described in population-based cohort studies. This arises when 
stiff and abnormally adherent red blood cells repeatedly impair blood flow to susceptible 
articular surfaces, causing bone infarction at the epiphyseal plates and early onset 
degenerative arthritis (Adesina, Brunson, Keegan, & Wun, 2017). The resultant hypoxia is 
the physiologic sequelae by which the microcellular bony environment adjusts. Adaptation to 
low oxygen tension (hypoxia) in cells and tissues leads to the transcriptional induction of a 
series of genes that participate in angiogenesis, iron metabolism, glucose metabolism, and 
cell proliferation/survival. The primary factor mediating this response is the hypoxia-inducible 
factor-1 (HIF-1), an oxygen-sensitive transcriptional activator (Ke & Costa, 2006). Several 
studies including this one has shown that HIF-1 can be upregulated dependently in response 
to hypoxia in osteoblast cells (Sun & Peng, 2015; Wan et al., 2010). The results in the 
present study are comparable to established experiments in the literature. This study 
confirms that prolonged hypoxia caused over expression of the hypoxic inducible factor. 
Although many experimental studies have looked at pathologic conditions including 
cancerous ones to establish the role of HIF in their pathogenesis (Carmeliet & Jain, 2000; 
Pralhad, Madhusudan, & Rajendrakumar, 2003), conditions such as sickle cell bone disease 
have little or no studies attributed to it, highlighting the role of HIF in the disease sequelae. 
Kyoung et al. speculated in their study that tissue hypoxia, which occurs in vasocculsion in 
SCD, infarction, and stroke, up-regulates the expression of chemokines, i.e., IL-8 in vascular 
endothelium (K. S. Kim, Rajagopal, Gonsalves, Johnson, & Kalra, 2006). However, the role 
of HIF was not highlighted in their study. This study however aimed to establish a basis for 
HIF over expression and contribute to the body of knowledge out there with regards 
angiogenesis and osteogenesis, which are consequences from the upregulation of the HIF 
pathway. 
Over the past decade, work from many laboratories have indicated that hypoxic 
microenvironments contribute to cancer progression by activating adaptive transcriptional 
programs that promote cell survival, motility, and tumor angiogenesis. Tumor cells residing 
closer to blood vessels are relatively well oxygenated, whereas those cells at more distant 
sites are hypoxic. Stabilization of HIF-α proteins in these cells stimulates the expression of 
numerous target genes encoding factors that mediate adaptation to hypoxic stress (Keith & 
Simon, 2007). These studies have proposed ways by which inhibiting the HIF pathway could 
help form therapeutic basis for cancer treatment. The results from this study showed that 
overexpression of HIF cascade of reactions could be a platform for osseointegration, which 
in this case is not an inhibition but a propagation of HIF. The role of the hypoxic inducible 
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factor in neoplasia pathogenesis has helped us draw some lessons in understanding its role 
in enhancing bone implant integration through its augmented expression as established in 
this study. 
Cobalt Chloride was introduced into MG63 cell culture samples as a mimetic for hypoxia. 
This was necessary to ensure adequate further mimicking of the in vivo microcellular 
environment seen in the pathologic process of avascular necrosis akin to that in sickle cell 
disease bone. In the laboratory such as in this case, with high-density cell culture methods, 
problems of oxygen deprivation become unavoidable with culture volumes exceeding only a 
few liters. Sparging of air or oxygen into mammalian cell culture growth media is not always 
suitable. It causes either damage to the cells by rupturing the membranes, or foaming and 
sometimes both (Fleischaker & Sinskey, 1981). In addition, studies have shown a 
discrepancy in the hypoxic modelling and partial pressure of oxygen is over stated. 
Established literature confirms that the partial pressure of oxygen (PaO2) in the bone marrow 
is 6.3% while in cells it is 1% (Carreau, El Hafny-Rahbi, Matejuk, Grillon, & Kieda, 2011). 
Although there is no documented evidence of measurement of PaO2 in SCD patients as far 
as we are aware, there have been studies suggesting mathematical and computational 
models which could advance this (Filas, Shui, & Beebe, 2013). However, it is assumed that 
with low haemoglobin levels in these patients, the PaO2 in these patients could be much 
lower than in normal patients hence the need to ensure and aim for pathologic hypoxia in 
this model as seen in SCD patients.  For this to be achieved with this experimental model - 
in other words simulating the in vivo conditions seen in SCD bone marrow, Cobalt Chloride 
was introduced to cell culture samples in order to ensure this. CoCl2 inhibits HIF-lα aryl 
hydrocarbon-hydroxylase activity to reduce HIF-lα degradation and so the features of Cobalt 
Chloride-simulated hypoxia are similar to those of the in vivo hypoxic microenvironment (B. 
Zhang et al., 2013). This could be the strength and strong selling point for this model. 
  
Furthermore, in designing the model for this experimental study, qPCR was used for the 
amplification of the test gene which was achieved after the cycle threshold (CT) values were 
normalized to two housekeeping genes-18S and GAPDH. Reverse transcriptase qPCR has 
been noted to be fast and delivers reliable and cost-effective results when it comes to gene 
expression. However, Dijkstra et al in their systemic review of published qPCR experiments 
noted that most experiments only used one reference gene and this reduces the validity of 
such experiments (Dijkstra et al., 2014a). We have used two reference genes in this study to 
ensure adequate validity but excellent validity could be desired if more than two reference 
genes were used. The results deduced here shows inconsistent results with decreased 
expression of HIF at 48 hours and increased expression at 72 hours when GAPDH alone is 
used as a reference gene. Although this trend is not seen with 18S as the reference gene, 
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these results further support the principle of normalization of the HIF expression with more 
than one reference gene to ensure validity. 
 
It is important to note that there were limitations with this model. Kitchen et al in their own 
study describe a method of estimating the components of biological variation and technical 
noise directly from qPCR measurements. This was achieved through the exploitation of a 
small number of biological and technical replicates at each stage of the sample processing 
procedure. These stages being the inter-subject, inter-sample, inter-RT, and inter-qPCR. 
These biological replicates form a pilot study to the larger main prospective investigation.  
(Kitchen, Kubista, & Tichopad, 2010). In the present study, this extensive and rather 
expensive method was not employed and hence this could be a limitation to the study. 
Another limitation to this study was that the results derived from the model developed was 
not validated using another test method. Real-time qPCR was used to determine the 
expression of HIF in the test samples and to further validate the results, enzyme linked 
immunosorbent assay (ELISA) could be used to assess the expression of HIF. The high 
sensitivity of qPCR allows for the detection of very low amounts of protein expression 
(Gomez et al., 2002). This formed the basis for its use in this model and in other 
experimental work but the novelty and usefulness of the model with the use of cobalt 
chloride could help lend more credence to this model by validation with ELISA (Dijkstra, van 
Kempen, Nagtegaal, & Bustin, 2014b). ELISA is a protein-based method while qPCR is 
DNA-based, and so there has been well-documented facts on the pros and cons of their use.  
ELISA is a quicker and easier method to carry out with less tissue handling and with no 
problems of RNA extraction and cDNA synthesis errors to overcome. However,  qPCR is 
less expensive and more specific (Adam T. Perestam, 2017). Some researchers have used 
both methods to help assess samples in order to aid validation of their results (Bensalah, 
2019; Nance, Riederer, Zubkowski, Trudel, & Rhodes, 2010). This was not the case in this 





This study sought to create an in vitro model to help establish the over expression of HIF in 
enhancing osseointegration. An in vitro model was developed in which MG63 osteoblast 
cells were cultured under hypoxic and normoxic conditions at 48 and 72 hours’ durations. 
The over expression of HIF was achieved within a few days (72 hours) with the introduction 
of Cobalt Chloride at the concentration of 300mM, which is a mimetic for hypoxia and 
making the investigation of avascular necrosis in pathologic conditions such as sickle cell 
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possible. It was noted that there was more over expression of HIF at a longer duration of 
culture at 72 hours. 
 This model was noted to be novel in its use in this work as it mimics the pathologic 
environment in which femoral implantation in THR takes place in vivo. To the best of the 
author’s knowledge, no other study has highlighted this.  However further questions arise 
pertaining to the metabolic viability of MG63 cells in which HIF is over expressed; could 
these osteoblastic cells in severe hypoxia have the functional metabolic activity to initiate 
satisfactory osseointegration? It is therefore crucial that further studies be done in order to 
scientifically establish this microcellular phenomenon and hence the need for the next study 























INVESTIGATING CELLULAR VIABILITY OF MG63 CELLS 
WITH COBALT CHLORIDE IN AN HYPOXIC 





Bone formation requires the contribution of osteogenic (bone-forming) connective tissue 
progenitors (CTP-Os). These progenitors represent a heterogenous population of cells in the 
bone marrow that are capable of proliferating and differentiating into one or more connective 
tissues (Heylman et al., 2014). In sickle cell, the pathogenesis of the disease condition leads 
to bone marrow hyperplasia and a sclerotic medullary canal (Azam & Sadat-Ali, 2016). This 
is the suboptimal bone environment that femoral implants are iinserted for those needing 
THR and this again does not encourage osseointegration. However, having suggested in the 
previous chapter that the proposed model could express the hypoxic inducible factor which 
invariable enhances osteogenesis, it is therefore important to ascertain if this osteogenic 
process in the presence of HIF expression could yield osteocytes with significant enough 
metabolic bioviability. This is one objective we seek to explore with an  in vitro model that 
could help investigate this. 
 
The prevalence of osteonecrosis in patients with sickle cell disease is very high, approaching 
50%. As demonstrated by various studies, progression to collapse is almost universal and 
the results of total hip replacement are much more problematic than in patients with other 
types of arthritis (Luck, 2006). Implant loosening rate is a major concern in these patients. It 
is hypothesized that the sequel of the disease, which includes vasocclusive crisis leading to 
repetitive bone infarction from hypoxia, could be the reason for lack of osseointegration of 
the prosthesis (Bishop et al., 1988; Moran, Huo, Garvin, Pellicci, & Salvati, 1993). There is 
still a paucity of studies aimed at highlighting this in these types of patients. 
Angiogenesis and osteogenesis are tightly coupled during bone development and 
regeneration. Mesenchymal cells in the developing stroma elicit angiogenic signals to recruit 
new blood vessels into bone. Reciprocal signals, likely emanating from the incoming 
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vascular endothelium, stimulate mesenchymal cell specification through additional 
interactions with cells within the vascular stem cell niche. The hypoxia-inducible factor-1 
alpha (HIF-1) pathway has been identified as a key component in this process (Wan et al., 
2010). It was obvious from the previous chapter that the HIF1 alpha protein over expressed 
in the hypoxic microcellular environment could be the experimental platform for further 
research into enhancing osseointegration in addressing the problem of prosthetic implant 
loosening in sickle cell disease patients. The model proposed still raised questions. One of 
such questions has to do with the lack of clarity on the role of cobalt chloride. Some studies 
have shown that the stimulatory effect of hypoxia on vasoactive endothelia factor VEGF can 
be reproduced by cobalt chloride. In addition, cobalt has been found to be a potent 
stimulator of VEGF in vivo (Minchenko, Bauer, Salceda, & Caro, 1994). 
 
The model in the previous chapter like other documented studies, highlighted the role of 
CoCl2 as a hypoxic mimetic ensuring true cellular hypoxia in order to mitigate well 
documented physiologic false positive hypoxic measurements in cell culture. With this in 
mind there is however no documented evidence in the literature of how much cellular 
metabolic activity takes place in hypoxic conditions when human MG63 cells are subjected 
to enhanced hypoxia in the presence of cobalt chloride. This study is aimed at assessing the 
level of osteoblastic cellular proliferative bioactivity in order to give credence to the earlier 
proposed experimental model investigating improved osseointegration in avascular necrosis 
based on over expressed HIF transciption protein in an hypoxic environment. It is further 
speculated that through this study, an experimental model design in co-operating cobalt 
chloride in the microcelluar  in vivo osteoblastic environment could be beneficial in 
developing a useful research model and may be effectual in adding to the little body of 
















Cell culture and passaging 
 
MG63 human osteosarcoma cells ( Sigma Aldrich) were cultured in cell media composed by 
volume of 87% Dulbecco’s Modified eagle medium (GlutaMax-1)DMEM- (Gibco Life 
Technologies):  10% Foetal Bovine Serum (FBS) - Sigma:  1% Non-essential Amino-acid 
(NEAA) 100x-(Sigma Life Science): 1% Penicillin-Stretomycin (P/S)- (Sigma Life Science): 
1% Sodium Pyruvate (NaPy)- (Sigma Life Science). Cells were seeded into 6-well plates at 
100,000 per well under two conditions in the incubator- 20% and 1% oxygen with 3µl of  
300mM of Cobalt Chloride. The normoxic cells without cobalt chloride were used as the 
control samples. All cell passaging was carried out under strict sterile conditions in the 
Biohood. The incubation period for the cells was 48 hours and 72 hours. Cell cultures were 
grown three times (n=3) on three separate consecutive occasions (N=3) at 48 hours and 72 
hours separately under the following conditions; - 20% normoxia with and without cobalt 
chloride: 1% hypoxic conditions with and without cobalt chloride. Cobalt chloride introduced 
to each well was used to enhance intracellular hypoxia due to reasons stated previously.   
 
 
Alamar Blue Assay to Assess Cellular Viability 
 
Following the duration of cell culture, Alamar Blue Assay was employed to assess MG63 
cellular viability. A stock solution of 0.15 mg/mL Resazurin/Alamar blue in Phosphate 
Buffered Saline (PBS) at pH 7.4 was prepared according to documented protocol. Stock 
solution was filtered and protected from light and stored at 4 degrees centigrade. 
After cell culture, 60µl of Alamar blue stock solution was added to each well without 
decanting the cell media and allowed to incubate for two hours protected from light.  
Fluorescence was then read at 560/590 nm using the Synergy HT Multi-Detection Microplate 
Reader- (BioTEK Instruments Inc.-Copyright 2006) - with the Microplate Data Collection and 
Analysis Software- (BioTEK Instruments Inc.-Copyright 2006- 2008). The Alamar blue 







Picogreen assay (Gibco Life Technologies) was used in this study to quantify the amount of 
DNA from the cultured cells, as dependent on cell number. Once the Alamar blue assay 
fluorescence signals was read, the cell culture media and Alamar blue reagent was 
aspirated carefully. Then each well of the cell plate was washed with PBS and then 
aspirated. 1X TE (Tris EDTA) buffer was added to each well and each well plate was then 
allowed to freeze/thaw under temperatures – 80 degrees and 25 degrees. This was done 
three times to release the DNA from the cells. 
The Picogreen reagent was then diluted in 1X TE buffer solution in a 1:200 ratio. Then 75µl 
of mixture with equal amount of prepared DNA/TE buffer put in a 96 well plate and 
absorbance readings taken. In addition, samples of known DNA concentrations were 
prepared and mixed with Picogreen reagent and fluorescence readings taken in order to 
generate DNA versus fluorescence standard curve (Figure A20).  Furthermore, in order to 
generate a standard curve of cell number versus Picogreen absorbance samples from 
known cell number also underwent the thaw/freeze sequence and mixed with the Picogreen 
reagent after which fluorescence readings were taken and the curve generated (Figure A21). 
Both standard curves were generated from triplicate assays (n=3) on three separate days 
(N=3) corresponding to the Alamar blue assays. The absorbance readings were then taken 
from the fluorospectrometer at 480nm/520 nm excitation. 
The standard curve of fluorescence/number of cells was used to determine how many cells 
were in the experimental samples. The data was normalised, as there was different number 
of cells in the experimental samples. This was done by dividing the average Alamar blue 
signal for each condition by the average number of cells for each condition and so signal 




The fluorescence ratios were calculated to evaluate the signals and data collated using 
Microsoft Excel software version 2016 (Microsoft Inc. Copyright 2016). Statistics analysis 
was carried out by using SPSS statistical software (version 24-IBM Cooperation Copyright 
1989, 2016). The data are expressed as mean ± SD and analysis was performed to indicate 
a statistically significant result p value of <0.05. The one-way ANOVA test (post Hoc Dunnett 
T3) was used and non-parametric data was analyzed using the Kruskal Wallis test to check 
for level of significance, p value <0.05 was deemed significant. Multiple Regression was 
used to assess the level of prediction for absorbance per cell. The assumptions for multiple 
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regression analysis as confirmed by the visual inspection of the histogram and normal P-P 
Plot (Figure A22) and the assumption of homoscedasticity of the data was fulfilled. A three-
way ANOVA was also carried out to check for the overall effect  of duration of culture, type of 
sample (hypoxic or normoxic) and presence of cobalt chloride on the absorbance per cell 




The results from the study were aimed at assessing osteoblastic cellular viability and 
proliferation under the various conditions highlighted previously. It was observed from the 
Alamar blue assay that there was statisitically difference in the absorbance per cell in 
samples cultured under the hypoxic conditions with CoCl2 chloride when compared with the 
control after 48hours (Table 4.1,Figure 4.1). The  mean signal per cell was more in the 
experimental sample (hypoxia with cobalt chloride- 0.01, p value <0.05) compared with the 
control (normoxia without cobalt chloride - 0.0007)  meaning increased cellular viability 
capacity despite the condition of hypoxia and presence of CoCl2. It was also noted that there 
was significant difference in the absorbance per cell with samples cultured under normoxia 
with CoCl2 (0.005, p value <0.05) when compared with the control (Table 4.1). The 
experimental samples also showed decreased viability and proliferation. This is expected 
due to the presence of cobalt chloride in normoxic conditions. 
 
The results was different after 72 hours duration. It was noted that there was  increased 
absorbance per cell under hypoxia with cobalt chloride (0.0025, p value >0.05) but there was 
no statisitically significant difference in the flouresence absorbance per cell when compared 
with the control of normoxia without chloride and the same is the case with increased 
absorbance per cell under hypoxia without chloride compared with the control, 0.002 (p 
value >0.05) and this difference was not significantly different (Table 4.2,Figure 4.2). 
Although there was observed increased absorbance per cell in the hypoxic samples with 
CoCl2 as compared to the normoxic cell samples with cobalt chloride (0.001, p value >0.05), 
this was not statisitically significant (Figure 4.2). Furthermore as seen in the 48 hour study, 
there was decreased absorbance per cell in samples cultured under normoxia without CoCl2 
as compared with similar samples with CoCl2. The reverse was the case in the normoxic 72 
hour samples. This could be due to the apoptosis effect of Cobalt Chloride enhanced in the 
72 hour samples due to the increased duration. The afore mentioned  trend is however not 
seen in the  72 hour hypoxic set of samples because of the expected lack of enhanced 
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expression of the hypoxic inducible factor in hypoxic samples without cobalt chloride. Here, 
there is decreased osteogenesis and the decreased absorbance in cells. 
The three way ANOVA  was used to determine the overall effect of the duration of culture, 
type of sample (either normoxic or hypoxic), presence of cobalt chloride or not on the 
absorbance per cell. There was no statistical interaction between these three parameters on 
the absorbance per cell, F(1,64) =2.311, p=0.133 ( p value signifcant at <0.05) (Field, 2013; 
Statistics, 2017b). 
A multiple regression was run to predict abosrbance per cell from the type of sample 
(normoxic or hypoxic); duration of culture (48hrs or 72hrs) and the presence of cobalt 
chloride (present or not). There was independence of residuals as assessed by a Durbin -
Watson statisic of 1.5. There was homoscedasticity as assessed by visual inspection of 
grouped scattered plots (Figures A23,A24,A25). 
The multiple regression model  statistically significantly predicted absorbance, F(3,68) 
=18.902, p<0.001, R2 = 0.455. Two of the variables (type of sample and duration of culture 
added significantly to the prediction, p<0.001: presence of cobalt chloride did not predict 
signficantly the absorbance per cell, p value =0.5 (Statistics, 2015b). The regression 






















Table 4.1- Showing multiple comparison of absorbance per cell at 48 hours under  the 
different experimental conditions.  
 
 
TYPE OF SAMPLE MEAN DIFFERENCE SIGNIFICANCE LEVEL 
(p value<0.05) 
Normoxia with Cobalt 
Chloride 
Compared with 




Normoxia without Cobalt 
Chloride 
Compared with Hypoxia 
with Cobalt Chloride 
 
0.0007* <0.05 
Hypoxia without Cobalt 
Chloride 
Compared with Normoxia 




Hypoxia with Cobalt 
Chloride 
Compared with Hypoxia 















FIGURE 4.1- Showing absorbance  per cell  under various experimental conditions at 48 
hours with normoxia without CoCl2 being the control. There was significant difference in the 
absorbance per cell under the hypoxic conditions with Cobalt Chloride compared to the 
control- normoxia with CoCl2-at 48hours: Kruskal Wallis test used to determine p value < 
0.05. One way ANOVA (post hoc. Dunnetts test) showed significant difference in 
absorbance per cell between control sample and normoxia with CoCl2 ,p = value <0.05. The 
above data was the S.E.M. of three independent measurements on three separate 









































Table 4.2- Showing multiple comparison of absorbance per cell at 72 hours under different  
experimental conditions.  
 
TYPE OF SAMPLE MEAN DIFFERENCE SIGNIFICANCE LEVEL 
(p value<0.05) 














Hypoxia without Cobalt 
Chloride 
Compared with 





Hypoxia with Cobalt 
Chloride 
Compared with 













FIGURE 4.2- Showing absorbance  per cell  under various experimental conditions at 72 
hours with normoxia without CoCl2 being the control. There was no significant difference in 
the absorbance per cell under the hypoxic conditions with Cobalt chloride compared to the 
control- normoxia without CoCl-at 72hours: Kruskal Wallis H (KWH) test used to determine p 
value > 0.05. One way ANOVA (post hoc. Dunnetts test) showed significant difference in 
absorbance per cell between the hypoxic without CoCl2 samples  and normoxia with CoCl2 
samples,  p value <0.05. The above data was the S.E.M. of three independent 








































Table 4.3- Table showing summary of multiple regression analysis highlighting the 





VARIABLE B S.EB β 
Intercept -0.001 1.23x10-5  
Duration 1.19x10-5 1.8x10-5 0.579* 
Type of sample 
(hypoxic/normoxic) 
6.9x10-5 1.8x10-5 0.340* 
Presence of cobalt 
chloride 
-1.23x10-5 1.8x10-5 -0.675 
 
NOTE- * level of significance p <0.001; B - Unstandardized regression coefficient ;  



























It has been established in the literature that the endothelial cell response to hypoxic stress 
can result in two different consequences in the surrounding tissues, depending on the 
duration of the exposure: short-term exposure causes physiological and reversible 
modulation of vascular tone and blood flow; chronic hypoxic stress results in irreversible 
remodelling of the vasculature and surrounding tissues, with smooth muscle proliferation and 
fibrosis. This dichotomy of responses to hypoxia may explain in part, both the acute and 
chronic pathophysiological sequelae of diseases characterized by regional hypoxia, 
including atherosclerosis, pulmonary hypertension, sickle cell disease and systemic sclerosis 
(Faller, 1999). However, it has been noted that these responses could also vary depending 
on different sensations and transduction of hypoxic and hyperoxic signals (Abidia, 2000).  
The results from our study sought to further establish and confirm the former assertion 
through the model employed. MG63 cells cultured under various hypoxic conditions and with 
a mimetic agent such as Cobalt Chloride seeks to mimic the in vivo pathologic microcellular 
environment seen in sickle cell disease avascular necrosis. It was observed in the 
experimental samples that there was increased cell viability at 48 hours for the hypoxic with 
CoCl2 samples. This is consistent with results seen in other studies, which highlights the role 
of HIF where hypoxia was noted to increase adhesion of MG63 spheroids and enhances 
their ability to spread into the surrounding fibroblast cell culture (Indovina, Rainaldi, & 
Santini, 2008). Grayson et al. hypothesized from the results in their study that the human 
mesenchymal cells cultured in hypoxic conditions displayed significantly improved expansion 
characteristics while maintaining their multi-lineage potential (Grayson, Zhao, Bunnell, & Ma, 
2007). However, this study further highlights the role of low partial pressure of oxygen (1%) 
by exaggerating the cellular level of hypoxia with the introduction of Cobalt Chloride, which 
to the best of our knowledge no other study has done when doing similar investigations. 
 
In this study the fact that short durations of hypoxia was employed (48 hours and 72 hours), 
results are similar to that seen in other studies where the experimental model involved 
culturing cells for up to 28 days (Potier et al., 2007). This may be akin to enhanced 
pathologic hypoxia but the introduction of Cobalt Chloride covers for this limitation and 
further authenticates the model in this study. However, there may be some variation in the 
results due to the increased apoptotic effect of CoCl2 and this was seen with the different 
absorbance per cells in samples cultured for 72 hours. There was no statistical difference in 
the level of cellular viability between the experimental samples and the control. This was not 
the case with the 48 hours’ samples showing significant difference. Although there was 
increased viability compared to the control at 72 hours this was not statistically significant. 
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There are credible reasons for this. There is established literature evidence describing the 
genotoxicity and cytotoxicity of cobalt ions behaviour in the cell culture medium of the 
nanomaterial studied (Ponti et al., 2009). The longer exposure to Cobalt Chloride could be 
responsible for the difference in results. This observation however confirms other 
hypotheses noted in various studies that CoCl2 prevents tumor formation in osteosarcoma 
cells and this could form the therapeutic basis for treatment of this neoplasia (B. Zhang et 
al., 2013). However, in contrast the regression analysis does show that CoCl2 is not a 
significant predictor of absorbance per cell unlike the duration of cell culture and whether or 
not the sample was hypoxic or normoxic. This could explain the variation in cellular viability 
noted in the 48 and 72 hour samples noted earlier. 
 
The experimental model employed in this study involved the Alamar blue assay. It was used 
to evaluate the MG63 cells in vitro for cellular viability and metabolic potential under the 
various experimental conditions, which is similar to the in vivo pathologic sickle cell 
environment. Alamar blue is a cell viability assay reagent that contains the cell 
permeable, non-toxic and weakly fluorescent blue indicator dye called Resazurin. 
Alamar Blue is a useful non-toxic alternative to the commonly used MTT cell viability 
assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (O'Brien, Wilson, 
Orton, & Pognan, 2000). Alamar Blue (AB) is a water-soluble dye that has been previously 
used for quantifying in vitro viability of various cells and because it is extremely stable and 
more importantly non-toxic to the cells, continuous monitoring of cultures over time is 
possible. Mainly for this reason, this test has been considered superior to classical tests for 
cell viability (Ahmed, Gogal, & Walsh, 1994; Fields & Lancaster, 1993). The Alamar Blue 
assay provides accurate time-course measurements. It has high sensitivity and linearity, 
involves no cell lysis, is ideal for use with post-measurement functional assays, is flexible 
and it can be used with different cell models. In addition, it is scalable and can be used with 
fluorescence and/or absorbance-based instrumentation platforms, and finally, it is non-toxic, 
non-radioactive and is safe for the user and the environment (Rampersad, 2012). Al-Nasiry 
et al established in their study that the use of Alamar blue assay was a reliable method of 
assessing the viability, migration and invasion of choriocarcinoma cells and so can be used 
as a model for invasive trophoblasts. Such models may prove valuable in the continuing 
search for assays which mimic the in vivo environment (Al-Nasiry et al., 2007). This present 
study also sought to achieve a similar goal which is to mimic the in vivo pathologic 
environment seen in sickle cell avascular pathology. The results from this study using the 
Alamar blue as a detector of cellular viability and proliferation highlights that osteoblasts 
cultured under hypoxic conditions in the presence of cobalt chloride could be a research 
platform, which establishes that the role of HIF could even be the foundation for improving 
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osseointegration in future implant design. This study highlights the experimental model used 
here as a possible research tool for further prosthetic implant design needed to address the 
matter of increased failure rate seen in sickle disease patients with total hip arthroplasty.  
There are some limitations to this model though, of which we are fully aware. The lack of 
validation of the results from this study using a concurrent study with the use of other assay 
methods to check cellular viability such as 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide (MTT) cell assays would give more credence to this model.  Though the 
MTT assay is less sensitive (Hamid, Rotshteyn, Rabadi, Parikh, & Bullock, 2004), this assay 
compares with  the Alamar blue assay and so comparison results would be helpful. In vivo 
animal studies may be useful to help validate this model in the future. Furthermore, there 
was no variation in the concentration of the CoCl2 used in order to check the cell response 
over intermediate lower concentrations of the mimetic agent. Bearing in mind the cytotoxicity 






This study aimed to assess the level of osteoblastic cellular proliferative bioactivity in order 
to give credence to the earlier proposed experimental model developed to investigate 
improved osseointegration in avascular necrosis, based on over expressed HIF transcription 
protein in a hypoxic environment. It was concluded that in the presence of low oxygen 
concentration (1%), osteoblasts as represented by MG63 cells are physiologically viable and 
so have functional potential. It was noted under prolonged duration of hypoxia (72 hours) 
and low oxygen saturation levels (1%) mimicking in vivo sickle cell bone marrow pathologic 
conditions; these cells did have some level of metabolic function. Despite the effects of 
CoCl2, which was used here to exaggerate the level of hypoxia, MG63 cells maintained 
some bioactivity and function. In this study, it was established that despite hypoxia, 
osteoblasts still maintain functional cellular function and this knowledge could act as a novel 
step in further investigating and improving bone-implant bonding in SCD patients. 
 In addition, we hypothesized that the Alamar blue assay used to investigate this 
phenomenon although not novel in its use could be adapted along with other assays in 
further research to investigate bone implant osseointegration. Adequate validation work on 
this model could help make it more effective in wider research involving the development of 










5.0 SUMMARY OF THESIS  
 
The main objective of this research work was to propose an experimental model which could 
be useful in further investigating osseointegration in the presence of a pathologic bony 
environment such as avascular necrosis as seen in SCD patients. A review of the literature 
was done highlighting the nature of SCD, the mode of failure of femoral implants in THR and 
its problems in these patients. Furthermore the role of the hypoxic inducible factor (HIF) was 
also brought to the fore and its effect as a useful protein in enhancing osseointegration was 
further explored. The questions raised in the review formed the basis for studies carried out 
in the research. It was first of all concluded through the clinical study work (chapter 2) that  
the shape of the proximal femur in sickle cell disease patients may have an effect on femoral 
component implant loosening. Also bearing in mind the sclerotic and hypoxic pathologic 
state of femoral bone marrow where the prosthesis is implanted, it is obvious that lack of 
osseointegration of the femoral component could be a factor. We therefore proceeded to 
explore the over expression of HIF- a protein which is expressed in hypoxic conditions 
similar to that seen in SCD patients (chapter 3). This was done through an in vitro model. 
The conclusion from this work confirmed that the model used could mimic the in vivo 
pathologic state and also express this osteogenic protein. These results could form the basis 
for exploring the improvement of osseointegration. In order to give some validation to this 
model, we sought to explore if the osteoblasts in the model proposed did maintain some 
metabolic and bioviability potential despite being cultured with cobalt chloride - a hypoxic 
mimetic (chapter 4). It was concluded that there was still some degree of osteoblast function 
despite the hypoxic environment ensured with culture in cobalt chloride. We therefore 
suggest that this model could be further validated through more research and the results 
may be extrapoliated to in vivo models and later translated into implant design and 





5.1 GENERAL DISCUSSION 
 
One of the objectives of this research study was to propose a durable experimental model 
that could serve as further research platform for reducing the revision burden for hip 
arthroplasty in sickle cell disease patients. Dampier et al. noted in their study that despite the 
increase in medical advances, sickle cell disease patients still had substantial impairment of 
health-related quality of life in adults that are influenced by only a few of many possible 
medical complications. It suggests that effective treatment of persistent pain and depression 
would provide the largest health related quality of life (HRQOL) benefit (Dampier et al., 
2011). One of the ways of addressing this in hip arthroplasty patients, is to help reduce the 
incidence of implant loosening and so effective osseointegration is important in achieving 
this. It is also important to note that there is little in the established literature that seeks to 
address the problem in this group of patients, hence the novelty of this experimental model, 
which could form a basis for addressing the problem of lack of osseointegration. 
 
The primary experiment in this study has established the role of the hypoxic inducible factor 
in its being over expressed under in vitro hypoxic conditions. This is consistent with current 
literature evidence as this oxygen response system helps enhance angiogenesis and then 
osteogenesis, which could ultimately lead to improve prosthesis implant osseointegration. 
The question still needs to be asked - is there a pathologic deficiency in the over expression 
of HIF in vivo with sickle cell disease patients? Hence the lack of implant integration. Ang et 
al noted in their study that in a disease like familial erythrocytosis (excessive red blood cell 
production) could be caused by homozygosity for a hypomorphic VHL (von Hippel-Lindau 
syndrome) allele (Ang et al., 2002). Maxell et al therefore noted in their review, that the 
altered VHL function is sufﬁcient to dysregulate erythropoiesis in humans. Presumably, this 
occurs by generating inappropriate signals in the ﬁbroblasts located in the kidney and so 
these patients have a minor defect in HIF regulation in all cells, rather than the major defect 
in some cells that is seen in classical VHL disease (Maxwell, 2005). Could the genetic 
pathology seen here be a casual effect or similar defect in sickle cell disease patients hence 
the lack of implant osseointegration seen in cases with hip arthroplasty? The existing body of 
literature evidence is devoid of these answers and so our study helps to raise an awareness 
and possible experimental discuss to help answer this important question. 
Orthopedic disease affects the majority of sickle cell anemia patients of which aseptic 
necrosis of the hip is the most common, occurring in up to 50% of patients (Vichinsky et al., 
1999) and total hip arthroplasty (THA) is the long term treatment for this. There are 
significant functional improvements which could be achieved after THA in patients with AVN 
(Lee, Lee, Seol, Park, & Yoon, 2017). However it has been shown in study after study that 
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patients with AVN from SCD are at a higher risk during total hip replacement surgery and in 
the early post-operative period. Approximately a 20% or higher failure rate is expected at a 
mean follow-up of 10 years. The multidisciplinary approach involving haematologists, 
anaesthetists, and orthopaedic surgeons should be used to reduce the incidence and 
severity of complications (Al-Mousawi et al., 2002). The increased life expectancy that 
medical advances have offered to the sickle cell patient has led to the increase in sickle-cell-
related complications, which were previously only seen rarely. These complications are then 
successfully managed (Al Elayan & Al Hamdan, 2012). This study has tried to put forward a 
proven hypothesis that the high failure rate seen in sickle cell disease patients with AVN 
treated with total hip arthroplasty can be managed.  As was concluded from the second 
chapter which was the clinical study preamble to the experimental work, it was concluded 
objectively that there might be structural reasons from the shape of the proximal femur of 
sickle disease patients that could cause implant loosening. This conclusion also helped us to 
further assume from the results of other studies that the pathologic sickle cell bony 
environment could be a contributing factor. Hence the need to address the problem of lack of 
osseointegration in these patients. 
 
The hypoxic inducible factor is an oxygen-sensitive transcriptional activator, which causes 
the transcriptional induction of a series of genes that participate in angiogenesis and 
osteogenesis (Ke & Costa, 2006). Various studies have established that osteoblasts are 
ideally situated in bone to sense oxygen tension and respond to hypoxia by activating the 
hypoxia inducible factor (HIF1α) pathway and provide evidence that HIF1α promotes 
angiogenesis and osteogenesis by elevating VEGF levels in osteoblasts (Rosová, Dao, 
Capoccia, Link, & Nolta, 2008; Wang et al., 2007). Based on this assertion, it was important 
to establish an experimental model to investigate the over expression of HIF in a 
microcellular environment which will mimic that seen in the sickle cell osteogenic pathology. 
In this model, the introduction of Cobalt Chloride was aimed at ensuring that true hypoxia 
was established in vitro as can be observed in vivo in these patients. The results from this 
study not only showed the up regulation of HIF as seen in documented studies but it also 
showed that the osteogenic protein HIF, could be augmented in the presence Cobalt 
Chloride. This could then play a crucial role in addressing the problem of implant loosening 
and improve osseointegration by the way of improved implant design.  
The new generation of improved hip prosthesis could be used in sickle cell disease patients 
needing hip arthroplasty. However, there is some body of evidence from literature that 
systemic arthroprosthetic cobaltism is an increasingly recognized complication of wear or 
corrosion of chrome-cobalt hip implants (Cheung et al., 2016; Gessner, Steck, Woelber, & 
Tower, 2015). We propose from the outcome of our work that the presence of cobalt would 
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only be as an agent for osseointegration and not a bearing surface as seen in other implant 
designs. 
 
In order to authenticate the experimental model proposed in this study, it was necessary to 
evaluate the cellular viability of MG63 cells cultured under the various experimental hypoxic 
conditions where HIF was over expressed. This was aimed at ensuring that there was 
osteogenic cellular viability of these cells that will help describe it as an effective and viable 
experimental model that could be used to investigate osseointegration. The results from the 
chapter four of this study, helps to establish that there was significant microcellular viability 
of MG63 cells after culture under 48 and 72 hours of true hypoxia. The role of cobalt chloride 
could be deduced from the 72 hour results, as there was no statistically significant difference 
in the results due to its apoptotic effects although there was increased viability as compared 
to the control samples. The results in this arm of the study, helps us to put forward this 
experimental model as novel in its use of Alamar blue assay in evaluating its role with the 
MG63 cells. There are few studies in the literature, which have done this. 
 
Sickle cell disease is a genetic disorder of growing global public health importance. 
More than 300,000 homozygous neonates (Haemogblobin SS) suffer from sickle cell 
anaemia (SCA). Recent estimates based on demographic  projections suggest that this 
number could rise to 400,000 by 2050 (Piel, Rees, & Williams, 2014; D. C. Rees, 2014). 
With the knowledge of the natural history of the pathology in mind, there would be an 
exponential increase in sickle cell patients needing hip arthroplasty surgery due to avascular 
necrosis hip degeneration and hence the increased revision burden. There is still paucity of 
research directed at answering questions about lack of implant osseointegration in these 
patients and this work seeks to form a foundational pathway for this with the intention of 
finding answers to the problem of implant loosening in these patients.  
 
The results from this study did show first of all that the shape of the proximal femur in SCD 
patients when compared with that of OA patients did contribute to femoral implant loosening 
due to its lesser funnel shape. This along with the already sclerotic bony marrow 
environment does contribute to little implant osseointegration. The lower cortical thickness 
deduced in these patients may possibly increase risk of occult periprosthetic fractures and 
hence cause more loosening. The study also showed that  that the microcellular bony 
environment of hypoxia is not a contraindication to osteogenesis and the in vitro model 
developed in this study showed the possiblity of over expression of HIF which could further 
enhance osseointegration in this compromised bony environment. The results noted from 
this model was then further verified by establishing that osetoblasts cultured in hypoxia, did 
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have functional potential and viabilty and so increasing its prospects for its future use in vivo. 
The experimental model developed here could be modified to further help design further 
models which could investigate osseointegration or the lack of it in sickle cell disease 
patients in vivo. With the further possibilty of HIF being over expressed in hypoxic conditions 
as shown in this model, there is an obvious futuristic potential of this osteogenic protein 
being used as a coating on femoral implants implanted in SCD patients in order to enhance 
osseointegration. Therefore more research work needs to be aimed at achieving this goal as 


































Hip arthroplasty implant failure in sickle cell disease patients continues to impact on the 
quality of life in these patients. With the increase in life expectancy in this group of patients, 
the surgical revision burden would exponentially increase, more so that most of these 
patients are young and active. The cost of revision is known to be signifcantly higher than 
the primary hip procedure in these cases. It is therefore imperative that directed research is 
undertaken to help improve implant osseontegration in these patients which would lead to 
improved survival rates. This would invariably in no small measure reduce significantly  the 
implant revision burden. This work ultimately sought to answer some questions about the 
lack of implant osseointegration. 
The clinical study carried out through radiographic evaluation highlighted that the shape of 
the proximal femur in sickle cell disease patients may be a causative factor in the failure of 
femoral component of the hip prosthesis. It was established that the proximal femur in these 
patients was funnel shaped allowing for some stable press fit implant fixation. However OA 
patients exhibited more funnel shaped femur and thicker cortices. This could represent 
increased risk of periprosthetic fracture in SC patients and eventually leading to less stable 
implant fixation. This may also led to the assumption that the lack of osseointegration could 
be the overarching factor in implant failure in these patients. 
An experimental model was then designed to help assess the expression of  the hypoxic 
inducible factor (HIF) an osteogenic protein in hypoxic conditions. This model sought to 
mimic the in vivo hypoxic pathologic bone environment seen in sickle cell disease patients. 
Here cobalt chloride was used as a hypoxic mimetic agent  and the cultured bone was 
assessed for its physiologic viability. The results from this arm of the study did show that HIF 
over expressed was a reality and bone cultured here had significant functional potential. 
The experimental model used here could be instrumental in forming the foundations for 
further in vivo studies directed at investigating and improving implant osseointegration in 
these group of patients. Cobalt could be an agent for enhancing osseointegration as shown 
here in this model in contrast to its use as a bearing sufrace in current implant technology. It 
is obvious that improved prosthesis design aimed at ensuring effective bone implant 
integration could use the template in this study as the basis for novel treatment of titanium 
surfaces and thus enhance bone-implant bonding which will invariably improve the quality of 
life of sickle cell disease patients with hip replacements. 
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6.1 FUTURE RESEARCH PROPOSALS 
 
 6.1.1 Scope of Problem 
 
There has been several experimental and clinical studies aimed at finding the ideal hip 
arthroplasty modality in sickle cell disease patients (Celebi et al., 2006; Gulati et al., 2015; 
Jack et al., 2016). The jury is still out on whether cemented or cementless implants give the 
best results. Some authors have suggested that due to lack of implant integration in these 
patients, cemented implants should be used. However others have speculated that cement, 
with its thermal effect, causes further necrosis of the already poorly vascularised bone and 
the necrosed bone may provide a better environment for the activation and growth of the 
dormant bacteria which are frequently cultured from the sickler’s bone (Sanjay & Moreau, 
1996).  It has also been suggested in this study previously that the proximal femur of SCD 
patients is funnel shaped and hence allowing for press fit prosthetic implantation to occur in 
these patients during hip arthroplasty procedures. Although it has been well documented  
that there are well founded surgical technical difficulties (Clarke et al., 1989; Platt, 
Rosenstock, & Espeland, 1984). Some studies with encouraging outcomes have been done 
looking at the results from cementless implants for osteonecrosis patients (Chiu, Shen, Ko, & 
Chan, 1997; Hartley, McAuley, Culpepper, & Engh, 2000). However, available literature is 
still devoid of  large numbered studies with significantly long term follow up in this group of 
patients  in order to discard doubts and controversies currently in the orthopaedic surgical 
community. This lack of clarity  further reinforces the need for more integrated research work 
aimed at addressing the question of implant loosening. Some of the suggestions for further 
research based on the results from this work are highlighted below. Furthermore there has 
been good and effective advances in the overall management of sickle cell anaemia through 
preventative and curative approaches to therapy (Ballas, 2002) and this has seen the life 
expectancy in these patients increase. It is therefore desirable that research is also directed 
at improving their quality of life through more enhanced osseointegration, thereby reducing 










6.2 Prospects for Improved Implant Design 
 
Hip implant design is crucial in addressing the problem of lack of osseointegration in sickle 
cell disease patients. Several studies in the literature have highlighted the use and efficacy 
of osteogenic-coated femoral stems in total hip arthroplasty. Many orthopaedic surgeons 
consider the use of hydroxyapatite (HA) for the potential advantages of increasing the 
strength of the implant-to-host bone bond and decreasing the amount of time required to 
achieve stable fixation (Cook et al., 1992; Soballe et al., 1991). Furthermore Sanz-Reig et al. 
showed in their studies that 98% of titanium plasma sprayed implant stems used in THA had 
signs of stability (endosteal bone formation and proximal adaptive bone remodeling) and 
61% had endosteal spot welds indicative of bony fixation (Sanz-Reig, Lizaur-Utrilla, Llamas-
Merino, & Lopez-Prats, 2011). In vitro and in vivo studies have shown the efficacy of 
osteogenic substrates such as human bone marrow stem cell seeded on poly (dl-lactic acid) 
scaffolds as potential biologic bone graft extended for future use in bone grafting (Bolland et 
al., 2008). It is also worth noting that other studies including randomized controlled trials 
have highlighted the lack of significant difference in clinical advantage for the use of HA 
coated implants (Camazzola, Hammond, Gandhi, & Davey, 2009). The reason for the 
disparity in the literature could be the need to further explore effective osseointegration in the 
design of hip implants. 
The results gleaned from this work showed that HIF, which is a hypoxic response protein, 
could be over-expressed in the microcellular hypoxic environment in the presence of cobalt 
chloride - a mimetic for hypoxia. It was also established that cellular viability was present 
even in this hypoxic environment, which was modelled after the osteopathologic environment 
seen in osteonecrosis – a component in the natural history in sickle cell bony disease. 
Knowing the complication of implant loosening in these patients, could HIF conjugated unto 
a known polysaccharide and seeded as a coating unto titanium hip implants be used to 
ensure effective osseointegration? A lot of work has been done in improving the titanium 
implant surface in order to enhance bony implant integration. Della et al suggested in their 
work that silicon based anodic spark deposition treatment of the titanium surface would 
enhance osseointegration in orthopaedic applications (Della Valle, Rondelli, Cigada, Bianchi, 
& Chiesa, 2013). In another study, they established that the modification treatment of the 
titanium surface could confer antibacterial properties, which could ensure osseointegration 
and prevent septic loosening (Della Valle et al., 2012). Sandrini et al also noted in their study 
that the novel biomimetic treatment of  the titanium surface, led to faster and durable implant 
to bone bonding through higher mineralization capacity (Sandrini, Chiesa, Rondelli, Santin, & 
Cigada, 2003). Having noted the above studies as references, our study could be used as 
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an experimental model to help improve the titanium surface osteogenic potential by treating 
it with HIF conjugated composite seeded on the implant. Like most of the studies referenced, 
this study is an in vitro model, which needs to be tested in vivo in order to establish its 
efficacy as a clinical application in sickle cell patients. Implant design research aimed at 
improved osseointegration could benefit from these proposals and the result would inevitably 
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FIGURE A1-Anterioposterior radiography of a 27 hear old female sickle cell patient with right 








INTEROBSERVER RELIABILITY DATA FOR SICKLE CELL GROUP (Tables A1 – A3) 
Table A1 Inter-item correlation Matrix for X (mid-diaphysis canal measurements). Intra-
class correlation excellent amongst observer measurements (p value <0.001). 
 
 
Table A2 Inter-Item Correlation Matrix for Y (proximal femoral canal measurements). 
Intra-class correlation excellent amongst observer measurements (p value<0.001) 
 Y1 Y2 Y3 
Y1 1.000 0.971 0.987 
Y2 0.971 1.000 0.985 
Y3 0.987 0.985 1.000 
    
 
 
Table A3 Inter-Item Correlation Matrix for Z- extra medullary diaphysis measurement. 
Intra-class correlation excellent amongst observer measurements (p value<0.001) 
1- Observer one: 2-observer two: 3 - observer three 
 
 Z1 Z2 Z3 
Z1 1.000 .991 0.992 
Z2 0.991 1.000 0.999 







 X1 X2 X3 
X1 1.000 0.992 0.997 
X2 0.992 1.000 0.995 
X3 0.997 0.995 1.000 
		 93	
INTEROBSERVER RELIABILITY DATA FOR OSTEOARTHRITIC GROUP (Tables A4-A6) 
Table A4 Inter-Item Correlation Matrix for x (mid-diaphysis canal measurements) O.A 
group. Intra-class correlation excellent amongst observer measurements (p value<0.001) 
 x1 x2 x3 
x1 1.000 0.907 0.478 
x2 0.907 1.000 0.472 




Table A5 Inter-Item Correlation Matrix for y (proximal femoral canal measurements). 
Intra-class correlation excellent amongst observer measurements (p value<0.001) 
 y1 y2 y3 
y1 1.000 .889 0.870 
y2 0.889 1.000 0.741 
y3 0.870 0.741 1.000 
 
 
Table A6 Inter-Item Correlation Matrix for z-extra medullary diaphysis measurement. 
Intra-class correlation excellent amongst observer measurements (p value<0.001) 
1-observer one: 2-observer two: 3-observer three 
 z1 z2 z3 
z1 1.000 0.461 0.531 
z2 0.461 1.000 0.906 







MICROSCOPIC IMAGES OF CELL CULTURE SAMPLES UNDER CONTROL 
(NORMOXIA) AND EXPERIMENTAL (HYPOXIC) CONDITIONS AT 48 HOURS AND 72 
HOURS WITH AND WITHOUT CHLORIDE 
 
Figure A2-MG63 cells cultured under 20% normoxia with cobalt chloride for 48hours 
(40x-magnification) 
 




Figure A4 - MG63 cells cultured under 1% hypoxia with cobalt chloride for 48hours 
(40x-magnification) 
 




Figure A6- MG63 cells cultured under 20% normoxia with cobalt chloride for 72hours 
(40x-magnification) 
  




















             Figure A10- Showing box plot for calcar canal ratio data with no outliers. 
 
 





 Figure A12- Showing Normal Q-Q plot of Calcar Canal ratio for Sickle Cell patients 

















Figure A13- Showing Normal Q-Q plot of Calcar canal ration for Osteoarthritis patients 











Figure A14 - Showing Normal Q-Q PLOT of Cortical Index (CI) for Sickle Cell  

















Figure A15 – Showing Normal Q-Q Plot for Cortical Index for Osteoarthritic patients- 
confirming normality of data. 
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Figure A16- Showing Scatter plot graph of Calcar Canal ratio versus Body Mass Index-  
Indicating a non-monotonic relationship. 
 
 
Figure A17- Showing Scatter plot graph of Cortical Index versus Body Mass Index-  
Indicating a non-monotonic relationship. 
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Figure A18- Showing Scatter plot graph of Cortical Index versus Age, 
Indicating a monotonic relationship 
 
 
Figure A19- Showing Scatter plot graph with fit line of Calcar canal  






FIGURE A20-  DNA standard curve for Picogreen Assay showing Absorbance versus DNA 






























Figure A21- MG63 Cell number standard curve for  picogreen assay showing Absorbance 
versus Cell number (n=3:N=3). 
 
 
Figure A22-Showing histogram showing standardized residuals for the absorbance per 


























Figure A23- Showing grouped scattered plot of absorbance per cell by type of sample, 


















Figure A24- Showing grouped scattered plot of absorbance per cell by duration of sample, 










Figure A25- Showing grouped scattered plot of absorbance per cell by presence of Cobalt 

















PHYSICAL CHARACTERIZATION EXPERIMENT FOR THE 




The objective of this experiment was to assess the baseline oxygen saturation reading of the 
incubator comparing the set measurements taken with the observed. The reason for this is 
to ascertain if the experimental conditions, which are 1% oxygen saturation- hypoxia under 
which cell samples were cultured, are stable and reproducible.   
 
MATERIALS AND METHODS 
The Galaxy R-oxygen incubator ((Model No. 170-300) - was connected to the nitrogen 
cylinder. The incubator oxygen sensor automatically calibrates to atmospheric levels. 
According to the incubators, instructional manual the incubator was set to 1% and the 
nitrogen released into the chamber. The incubator has previously been connected to the 




The readings for the set and observed  partial pressure of oxygen in the incubator chamber 
shows that a similar trend of readings (See Figures 18 and 19). The mean readings for the 
observed partial pressure of oxygen in the chamber was 1.13%, range (1.04 - 1.23). When 
comparing the mean reading of the set pressures which was 1%  to the observed over the 










Figure A26- Showing incubator oxygen concentration over the first 12 hours with the trend 
of the observed and the set partial pressure of oxygen in the incubator chamber. It shows 





















































































































































Figure A27- Showing incubator oxygen concentration over the next 12 hours with the trend 
of the observed and the set partial pressure of oxygen in the incubator chamber. Please note 





It is clear from the above results that the set reading for the partial pressure of oxygen in the 
incubator chamber is not significantly different from the actual observed readings. This 
shows that the environmental hypoxic condition in the chamber can be reliable and the same 
can be concluded for the Galaxy R- oxygen incubator used for the hypoxic cell culture in this 
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